src/jalview/fts/service/pdb/PDBFTSRestClient.java

   1 /*
   2  * Jalview - A Sequence Alignment Editor and Viewer ($$Version-Rel$$)
   3  * Copyright (C) $$Year-Rel$$ The Jalview Authors
   4  *
   5  * This file is part of Jalview.
   6  *
   7  * Jalview is free software: you can redistribute it and/or
   8  * modify it under the terms of the GNU General Public License
   9  * as published by the Free Software Foundation, either version 3
  10  * of the License, or (at your option) any later version.
  11  *
  12  * Jalview is distributed in the hope that it will be useful, but
  13  * WITHOUT ANY WARRANTY; without even the implied warranty
  14  * of MERCHANTABILITY or FITNESS FOR A PARTICULAR
  15  * PURPOSE.  See the GNU General Public License for more details.
  16  *
  17  * You should have received a copy of the GNU General Public License
  18  * along with Jalview.  If not, see <http://www.gnu.org/licenses/>.
  19  * The Jalview Authors are detailed in the 'AUTHORS' file.
  20  */
  21 package jalview.fts.service.pdb;
  22
  23 import java.net.URI;
  24 import java.util.ArrayList;
  25 import java.util.Collection;
  26 import java.util.Iterator;
  27 import java.util.List;
  28 import java.util.Map;
  29 import java.util.Objects;
  30
  31 import javax.ws.rs.core.MediaType;
  32
  33 import org.json.simple.parser.ParseException;
  34
  35 import com.sun.jersey.api.client.Client;
  36 import com.sun.jersey.api.client.ClientResponse;
  37 import com.sun.jersey.api.client.WebResource;
  38 import com.sun.jersey.api.client.config.DefaultClientConfig;
  39
  40 import jalview.datamodel.SequenceI;
  41 import jalview.fts.api.FTSData;
  42 import jalview.fts.api.FTSDataColumnI;
  43 import jalview.fts.api.FTSRestClientI;
  44 import jalview.fts.api.StructureFTSRestClientI;
  45 import jalview.fts.core.FTSDataColumnPreferences;
  46 import jalview.fts.core.FTSDataColumnPreferences.PreferenceSource;
  47 import jalview.fts.core.FTSRestClient;
  48 import jalview.fts.core.FTSRestRequest;
  49 import jalview.fts.core.FTSRestResponse;
  50 import jalview.fts.service.alphafold.AlphafoldRestClient;
  51 import jalview.util.JSONUtils;
  52 import jalview.util.MessageManager;
  53 import jalview.util.Platform;
  54
  55 /**
  56  * A rest client for querying the Search endpoint of the PDB API
  57  *
  58  * @author tcnofoegbu
  59  */
  60 public class PDBFTSRestClient extends FTSRestClient implements StructureFTSRestClientI
  61 {
  62
  63   private static FTSRestClientI instance = null;
  64
  65   public static final String PDB_SEARCH_ENDPOINT = "https://www.ebi.ac.uk/pdbe/search/pdb/select?";
  66
  67   protected PDBFTSRestClient()
  68   {
  69   }
  70
  71   /**
  72    * Takes a PDBRestRequest object and returns a response upon execution
  73    *
  74    * @param pdbRestRequest
  75    *          the PDBRestRequest instance to be processed
  76    * @return the pdbResponse object for the given request
  77    * @throws Exception
  78    */
  79   @SuppressWarnings({ "unused", "unchecked" })
  80   @Override
  81   public FTSRestResponse executeRequest(FTSRestRequest pdbRestRequest)
  82           throws Exception
  83   {
  84     try
  85     {
  86       String wantedFields = getDataColumnsFieldsAsCommaDelimitedString(
  87               pdbRestRequest.getWantedFields());
  88       int responseSize = (pdbRestRequest.getResponseSize() == 0)
  89               ? getDefaultResponsePageSize()
  90               : pdbRestRequest.getResponseSize();
  91       int offSet = pdbRestRequest.getOffSet();
  92       String sortParam = null;
  93       if (pdbRestRequest.getFieldToSortBy() == null
  94               || pdbRestRequest.getFieldToSortBy().trim().isEmpty())
  95       {
  96         sortParam = "";
  97       }
  98       else
  99       {
 100         if (pdbRestRequest.getFieldToSortBy()
 101                 .equalsIgnoreCase("Resolution"))
 102         {
 103           sortParam = pdbRestRequest.getFieldToSortBy()
 104                   + (pdbRestRequest.isAscending() ? " asc" : " desc");
 105         }
 106         else
 107         {
 108           sortParam = pdbRestRequest.getFieldToSortBy()
 109                   + (pdbRestRequest.isAscending() ? " desc" : " asc");
 110         }
 111       }
 112
 113       String facetPivot = (pdbRestRequest.getFacetPivot() == null
 114               || pdbRestRequest.getFacetPivot().isEmpty()) ? ""
 115                       : pdbRestRequest.getFacetPivot();
 116       String facetPivotMinCount = String
 117               .valueOf(pdbRestRequest.getFacetPivotMinCount());
 118
 119       String query = pdbRestRequest.getFieldToSearchBy()
 120               + pdbRestRequest.getSearchTerm()
 121               + (pdbRestRequest.isAllowEmptySeq() ? ""
 122                       : " AND molecule_sequence:['' TO *]")
 123               + (pdbRestRequest.isAllowUnpublishedEntries() ? ""
 124                       : " AND status:REL");
 125
 126       // Build request parameters for the REST Request
 127
 128       // BH 2018 the trick here is to coerce the classes in Javascript to be
 129       // different from the ones in Java yet still allow this to be correct for Java
 130       Client client;
 131       Class<ClientResponse> clientResponseClass;
 132       if (Platform.isJS())
 133       {
 134         // JavaScript only -- coerce types to Java types for Java
 135         client = (Client) (Object) new jalview.javascript.web.Client();
 136         clientResponseClass = (Class<ClientResponse>) (Object) jalview.javascript.web.ClientResponse.class;
 137       }
 138       else
 139       /**
 140        * Java only
 141        *
 142        * @j2sIgnore
 143        */
 144       {
 145         client = Client.create(new DefaultClientConfig());
 146         clientResponseClass = ClientResponse.class;
 147       }
 148
 149       WebResource webResource;
 150       if (pdbRestRequest.isFacet())
 151       {
 152         webResource = client.resource(PDB_SEARCH_ENDPOINT)
 153                 .queryParam("wt", "json").queryParam("fl", wantedFields)
 154                 .queryParam("rows", String.valueOf(responseSize))
 155                 .queryParam("q", query)
 156                 .queryParam("start", String.valueOf(offSet))
 157                 .queryParam("sort", sortParam).queryParam("facet", "true")
 158                 .queryParam("facet.pivot", facetPivot)
 159                 .queryParam("facet.pivot.mincount", facetPivotMinCount);
 160       }
 161       else
 162       {
 163         webResource = client.resource(PDB_SEARCH_ENDPOINT)
 164                 .queryParam("wt", "json").queryParam("fl", wantedFields)
 165                 .queryParam("rows", String.valueOf(responseSize))
 166                 .queryParam("start", String.valueOf(offSet))
 167                 .queryParam("q", query).queryParam("sort", sortParam);
 168       }
 169
 170       URI uri = webResource.getURI();
 171
 172       System.out.println(uri);
 173       ClientResponse clientResponse =null;
 174       int responseStatus = -1;
 175       // Get the JSON string from the response object or directly from the
 176       // client (JavaScript)
 177       Map<String, Object> jsonObj = null;
 178       String responseString = null;
 179
 180       System.out.println("query >>>>>>> " + pdbRestRequest.toString());
 181
 182       if (!isMocked())
 183       {
 184         // Execute the REST request
 185         clientResponse = webResource.accept(MediaType.APPLICATION_JSON)
 186                 .get(clientResponseClass);
 187         responseStatus = clientResponse.getStatus();
 188       }
 189       else
 190       {
 191         // mock response
 192         if (mockQueries.containsKey(uri.toString()))
 193         {
 194           responseStatus = 200;
 195         }
 196         else
 197         {
 198           // FIXME - may cause unexpected exceptions for callers when mocked
 199           responseStatus = 400;
 200         }
 201       }
 202
 203       // Check the response status and report exception if one occurs
 204       switch (responseStatus)
 205       {
 206       case 200:
 207
 208         if (isMocked())
 209         {
 210           responseString = mockQueries.get(uri.toString());
 211         }
 212         else
 213         {
 214           if (Platform.isJS())
 215           {
 216             jsonObj = clientResponse.getEntity(Map.class);
 217           }
 218           else
 219           {
 220             responseString = clientResponse.getEntity(String.class);
 221           }
 222         }
 223         break;
 224       case 400:
 225         throw new Exception(isMocked() ? "400 response (Mocked)" : parseJsonExceptionString(responseString));
 226       default:
 227         throw new Exception(
 228                 getMessageByHTTPStatusCode(responseStatus, "PDB"));
 229       }
 230
 231       // Process the response and return the result to the caller.
 232       return parsePDBJsonResponse(responseString, jsonObj, pdbRestRequest);
 233     } catch (Exception e)
 234     {
 235       if (e.getMessage()==null)
 236       {
 237         throw(e);
 238       }
 239       String exceptionMsg = e.getMessage();
 240       if (exceptionMsg.contains("SocketException"))
 241       {
 242         // No internet connection
 243         throw new Exception(MessageManager.getString(
 244                 "exception.unable_to_detect_internet_connection"));
 245       }
 246       else if (exceptionMsg.contains("UnknownHostException"))
 247       {
 248         // The server 'www.ebi.ac.uk' is unreachable
 249         throw new Exception(MessageManager.formatMessage(
 250                 "exception.fts_server_unreachable", "PDB Solr"));
 251       }
 252       else
 253       {
 254         throw e;
 255       }
 256     }
 257   }
 258
 259   /**
 260    * Process error response from PDB server if/when one occurs.
 261    *
 262    * @param jsonResponse
 263    *          the JSON string containing error message from the server
 264    * @return the processed error message from the JSON string
 265    */
 266   @SuppressWarnings("unchecked")
 267 public static String parseJsonExceptionString(String jsonErrorResponse)
 268   {
 269     StringBuilder errorMessage = new StringBuilder(
 270             "\n============= PDB Rest Client RunTime error =============\n");
 271
 272
 273 //    {
 274 //      "responseHeader":{
 275 //        "status":0,
 276 //        "QTime":0,
 277 //        "params":{
 278 //          "q":"(text:q93xj9_soltu) AND molecule_sequence:['' TO *] AND status:REL",
 279 //          "fl":"pdb_id,title,experimental_method,resolution",
 280 //          "start":"0",
 281 //          "sort":"overall_quality desc",
 282 //          "rows":"500",
 283 //          "wt":"json"}},
 284 //      "response":{"numFound":1,"start":0,"docs":[
 285 //          {
 286 //            "experimental_method":["X-ray diffraction"],
 287 //            "pdb_id":"4zhp",
 288 //            "resolution":2.46,
 289 //            "title":"The crystal structure of Potato ferredoxin I with 2Fe-2S cluster"}]
 290 //      }}
 291 //
 292     try
 293     {
 294       Map<String, Object> jsonObj = (Map<String, Object>) JSONUtils.parse(jsonErrorResponse);
 295       Map<String, Object> errorResponse = (Map<String, Object>) jsonObj.get("error");
 296
 297       Map<String, Object> responseHeader = (Map<String, Object>) jsonObj
 298               .get("responseHeader");
 299       Map<String, Object> paramsObj = (Map<String, Object>) responseHeader.get("params");
 300       String status = responseHeader.get("status").toString();
 301       String message = errorResponse.get("msg").toString();
 302       String query = paramsObj.get("q").toString();
 303       String fl = paramsObj.get("fl").toString();
 304
 305       errorMessage.append("Status: ").append(status).append("\n");
 306       errorMessage.append("Message: ").append(message).append("\n");
 307       errorMessage.append("query: ").append(query).append("\n");
 308       errorMessage.append("fl: ").append(fl).append("\n");
 309
 310     } catch (ParseException e)
 311     {
 312       e.printStackTrace();
 313     }
 314     return errorMessage.toString();
 315   }
 316
 317   /**
 318    * Parses the JSON response string from PDB REST API. The response is dynamic
 319    * hence, only fields specifically requested for in the 'wantedFields'
 320    * parameter is fetched/processed
 321    *
 322    * @param pdbJsonResponseString
 323    *          the JSON string to be parsed
 324    * @param pdbRestRequest
 325    *          the request object which contains parameters used to process the
 326    *          JSON string
 327    * @return
 328    */
 329   public static FTSRestResponse parsePDBJsonResponse(
 330           String pdbJsonResponseString, FTSRestRequest pdbRestRequest)
 331   {
 332     return parsePDBJsonResponse(pdbJsonResponseString,
 333             (Map<String, Object>) null, pdbRestRequest);
 334   }
 335
 336   @SuppressWarnings("unchecked")
 337   public static FTSRestResponse parsePDBJsonResponse(
 338           String pdbJsonResponseString, Map<String, Object> jsonObj,
 339           FTSRestRequest pdbRestRequest)
 340   {
 341     FTSRestResponse searchResult = new FTSRestResponse();
 342     List<FTSData> result = null;
 343     try
 344     {
 345       if (jsonObj == null)
 346       {
 347         jsonObj = (Map<String, Object>) JSONUtils.parse(pdbJsonResponseString);
 348       }
 349       Map<String, Object> pdbResponse = (Map<String, Object>) jsonObj.get("response");
 350       String queryTime = ((Map<String, Object>) jsonObj.get("responseHeader"))
 351               .get("QTime").toString();
 352       int numFound = Integer
 353               .valueOf(pdbResponse.get("numFound").toString());
 354       List<Object> docs = (List<Object>) pdbResponse.get("docs");
 355
 356       result = new ArrayList<FTSData>();
 357       if (numFound > 0)
 358       {
 359
 360         for (Iterator<Object> docIter = docs.iterator(); docIter
 361                 .hasNext();)
 362         {
 363           Map<String, Object> doc = (Map<String, Object>) docIter.next();
 364           result.add(getFTSData(doc, pdbRestRequest));
 365         }
 366       }
 367       // this is the total number found by the query,
 368       // rather than the set returned in SearchSummary
 369       searchResult.setNumberOfItemsFound(numFound);
 370       searchResult.setResponseTime(queryTime);
 371       searchResult.setSearchSummary(result);
 372
 373     } catch (ParseException e)
 374     {
 375       e.printStackTrace();
 376     }
 377     return searchResult;
 378   }
 379
 380   public static FTSData getFTSData(Map<String, Object> pdbJsonDoc,
 381           FTSRestRequest request)
 382   {
 383
 384     String primaryKey = null;
 385
 386     Object[] summaryRowData;
 387
 388     SequenceI associatedSequence;
 389
 390     Collection<FTSDataColumnI> diplayFields = request.getWantedFields();
 391     SequenceI associatedSeq = request.getAssociatedSequence();
 392     int colCounter = 0;
 393     summaryRowData = new Object[(associatedSeq != null)
 394             ? diplayFields.size() + 1
 395             : diplayFields.size()];
 396     if (associatedSeq != null)
 397     {
 398       associatedSequence = associatedSeq;
 399       summaryRowData[0] = associatedSequence;
 400       colCounter = 1;
 401     }
 402
 403     for (FTSDataColumnI field : diplayFields)
 404     {
 405       //System.out.println("Field " + field);
 406       String fieldData = (pdbJsonDoc.get(field.getCode()) == null) ? ""
 407               : pdbJsonDoc.get(field.getCode()).toString();
 408       //System.out.println("Field Data : " + fieldData);
 409       if (field.isPrimaryKeyColumn())
 410       {
 411         primaryKey = fieldData;
 412         summaryRowData[colCounter++] = primaryKey;
 413       }
 414       else if (fieldData == null || fieldData.isEmpty())
 415       {
 416         summaryRowData[colCounter++] = null;
 417       }
 418       else
 419       {
 420         try
 421         {
 422           summaryRowData[colCounter++] = (field.getDataType()
 423                   .getDataTypeClass() == Integer.class)
 424                           ? Integer.valueOf(fieldData)
 425                           : (field.getDataType()
 426                                   .getDataTypeClass() == Double.class)
 427                                           ? Double.valueOf(fieldData)
 428                                           : sanitiseData(fieldData);
 429         } catch (Exception e)
 430         {
 431           e.printStackTrace();
 432           System.out.println("offending value:" + fieldData);
 433         }
 434       }
 435     }
 436
 437     final String primaryKey1 = primaryKey;
 438
 439     final Object[] summaryRowData1 = summaryRowData;
 440     return new FTSData()
 441     {
 442       @Override
 443       public Object[] getSummaryData()
 444       {
 445         return summaryRowData1;
 446       }
 447
 448       @Override
 449       public Object getPrimaryKey()
 450       {
 451         return primaryKey1;
 452       }
 453
 454       /**
 455        * Returns a string representation of this object;
 456        */
 457       @Override
 458       public String toString()
 459       {
 460         StringBuilder summaryFieldValues = new StringBuilder();
 461         for (Object summaryField : summaryRowData1)
 462         {
 463           summaryFieldValues.append(
 464                   summaryField == null ? " " : summaryField.toString())
 465                   .append("\t");
 466         }
 467         return summaryFieldValues.toString();
 468       }
 469
 470       /**
 471        * Returns hash code value for this object
 472        */
 473       @Override
 474       public int hashCode()
 475       {
 476         return Objects.hash(primaryKey1, this.toString());
 477       }
 478
 479       @Override
 480       public boolean equals(Object that)
 481       {
 482         return this.toString().equals(that.toString());
 483       }
 484     };
 485   }
 486
 487   private static String sanitiseData(String data)
 488   {
 489     String cleanData = data.replaceAll("\\[\"", "").replaceAll("\\]\"", "")
 490             .replaceAll("\\[", "").replaceAll("\\]", "")
 491             .replaceAll("\",\"", ", ").replaceAll("\"", "");
 492     return cleanData;
 493   }
 494
 495   @Override
 496   public String getColumnDataConfigFileName()
 497   {
 498     return "/fts/pdb_data_columns.txt";
 499   }
 500
 501   public static FTSRestClientI getInstance()
 502   {
 503     if (instance == null)
 504     {
 505       instance = new PDBFTSRestClient();
 506     }
 507     return instance;
 508   }
 509
 510   private Collection<FTSDataColumnI> allDefaultDisplayedStructureDataColumns;
 511   @Override
 512   public Collection<FTSDataColumnI> getAllDefaultDisplayedStructureDataColumns()
 513   {
 514     if (allDefaultDisplayedStructureDataColumns == null
 515             || allDefaultDisplayedStructureDataColumns.isEmpty())
 516     {
 517       allDefaultDisplayedStructureDataColumns = new ArrayList<>();
 518       allDefaultDisplayedStructureDataColumns
 519               .addAll(super.getAllDefaultDisplayedFTSDataColumns());
 520     }
 521     return allDefaultDisplayedStructureDataColumns;
 522   }
 523   @Override
 524   public String[] getPreferencesColumnsFor(PreferenceSource source) {
 525     String[] columnNames = null;
 526     switch (source)
 527     {
 528     case SEARCH_SUMMARY:
 529       columnNames = new String[] { "", "Display", "Group" };
 530       break;
 531     case STRUCTURE_CHOOSER:
 532       columnNames = new String[] { "", "Display", "Group" };
 533       break;
 534     case PREFERENCES:
 535       columnNames = new String[] { "PDB Field", "Show in search summary",
 536           "Show in structure summary" };
 537       break;
 538     default:
 539       break;
 540     }
 541     return columnNames;
 542   }
 543
 544   public static void setMock()
 545   {
 546     String[][] mocks= {{ "https://www.ebi.ac.uk/pdbe/search/pdb/select?wt=json&fl=pdb_id,title,experimental_method,resolution&rows=500&start=0&q=(4igk+OR+1t15+OR+4ifi+OR+1t29+OR+3pxb+OR+4y2g+OR+1y98+OR+1jnx+OR+3pxa+OR+3k0h+OR+3k0k+OR+1n5o+OR+3pxc+OR+3pxd+OR+1t2u+OR+3k15+OR+3pxe+OR+3k16+OR+4ofb+OR+3coj+OR+7lyb+OR+1t2v+OR+4y18+OR+4jlu+OR+4u4a+OR+2ing+OR+7jzv+OR+6g2i+OR+1jm7+OR+1oqa)+AND+molecule_sequence:%5B''+TO+*%5D+AND+status:REL&sort=",
 547             "{\n"
 548             + "  \"responseHeader\":{\n"
 549             + "    \"status\":0,\n"
 550             + "    \"QTime\":0,\n"
 551             + "    \"params\":{\n"
 552             + "      \"q\":\"(4igk OR 1t15 OR 4ifi OR 1t29 OR 3pxb OR 4y2g OR 1y98 OR 1jnx OR 3pxa OR 3k0h OR 3k0k OR 1n5o OR 3pxc OR 3pxd OR 1t2u OR 3k15 OR 3pxe OR 3k16 OR 4ofb OR 3coj OR 7lyb OR 1t2v OR 4y18 OR 4jlu OR 4u4a OR 2ing OR 7jzv OR 6g2i OR 1jm7 OR 1oqa) AND molecule_sequence:['' TO *] AND status:REL\",\n"
 553             + "      \"fl\":\"pdb_id,title,experimental_method,resolution\",\n"
 554             + "      \"start\":\"0\",\n"
 555             + "      \"sort\":\"\",\n"
 556             + "      \"rows\":\"500\",\n"
 557             + "      \"wt\":\"json\"}},\n"
 558             + "  \"response\":{\"numFound\":64,\"start\":0,\"docs\":[\n"
 559             + "      {\n"
 560             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 561             + "        \"pdb_id\":\"4ofb\",\n"
 562             + "        \"resolution\":3.05,\n"
 563             + "        \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
 564             + "      {\n"
 565             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 566             + "        \"pdb_id\":\"3pxe\",\n"
 567             + "        \"resolution\":2.85,\n"
 568             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
 569             + "      {\n"
 570             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 571             + "        \"pdb_id\":\"4jlu\",\n"
 572             + "        \"resolution\":3.5,\n"
 573             + "        \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
 574             + "      {\n"
 575             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 576             + "        \"pdb_id\":\"4y2g\",\n"
 577             + "        \"resolution\":2.5,\n"
 578             + "        \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
 579             + "      {\n"
 580             + "        \"experimental_method\":[\"Solution NMR\"],\n"
 581             + "        \"pdb_id\":\"1oqa\",\n"
 582             + "        \"title\":\"Solution structure of the BRCT-c domain from human BRCA1\"},\n"
 583             + "      {\n"
 584             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 585             + "        \"pdb_id\":\"4u4a\",\n"
 586             + "        \"resolution\":3.51,\n"
 587             + "        \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
 588             + "      {\n"
 589             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 590             + "        \"pdb_id\":\"1t2v\",\n"
 591             + "        \"resolution\":3.3,\n"
 592             + "        \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
 593             + "      {\n"
 594             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 595             + "        \"pdb_id\":\"3k15\",\n"
 596             + "        \"resolution\":2.8,\n"
 597             + "        \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
 598             + "      {\n"
 599             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 600             + "        \"pdb_id\":\"1t15\",\n"
 601             + "        \"resolution\":1.85,\n"
 602             + "        \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
 603             + "      {\n"
 604             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 605             + "        \"pdb_id\":\"3k16\",\n"
 606             + "        \"resolution\":3.0,\n"
 607             + "        \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
 608             + "      {\n"
 609             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 610             + "        \"pdb_id\":\"1t29\",\n"
 611             + "        \"resolution\":2.3,\n"
 612             + "        \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
 613             + "      {\n"
 614             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 615             + "        \"pdb_id\":\"1y98\",\n"
 616             + "        \"resolution\":2.5,\n"
 617             + "        \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
 618             + "      {\n"
 619             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 620             + "        \"pdb_id\":\"4ifi\",\n"
 621             + "        \"resolution\":2.2,\n"
 622             + "        \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
 623             + "      {\n"
 624             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 625             + "        \"pdb_id\":\"3k0k\",\n"
 626             + "        \"resolution\":2.7,\n"
 627             + "        \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
 628             + "      {\n"
 629             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 630             + "        \"pdb_id\":\"3k0h\",\n"
 631             + "        \"resolution\":2.7,\n"
 632             + "        \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
 633             + "      {\n"
 634             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 635             + "        \"pdb_id\":\"3pxd\",\n"
 636             + "        \"resolution\":2.8,\n"
 637             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1835P\"},\n"
 638             + "      {\n"
 639             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 640             + "        \"pdb_id\":\"3pxc\",\n"
 641             + "        \"resolution\":2.8,\n"
 642             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: R1699Q\"},\n"
 643             + "      {\n"
 644             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 645             + "        \"pdb_id\":\"3pxa\",\n"
 646             + "        \"resolution\":2.55,\n"
 647             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: G1656D\"},\n"
 648             + "      {\n"
 649             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 650             + "        \"pdb_id\":\"1jnx\",\n"
 651             + "        \"resolution\":2.5,\n"
 652             + "        \"title\":\"Crystal structure of the BRCT repeat region from the breast cancer associated protein, BRCA1\"},\n"
 653             + "      {\n"
 654             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 655             + "        \"pdb_id\":\"4igk\",\n"
 656             + "        \"resolution\":1.75,\n"
 657             + "        \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
 658             + "      {\n"
 659             + "        \"experimental_method\":[\"Solution NMR\"],\n"
 660             + "        \"pdb_id\":\"1jm7\",\n"
 661             + "        \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
 662             + "      {\n"
 663             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 664             + "        \"pdb_id\":\"4jlu\",\n"
 665             + "        \"resolution\":3.5,\n"
 666             + "        \"title\":\"Crystal structure of BRCA1 BRCT with doubly phosphorylated Abraxas\"},\n"
 667             + "      {\n"
 668             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 669             + "        \"pdb_id\":\"6g2i\",\n"
 670             + "        \"resolution\":5.9,\n"
 671             + "        \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
 672             + "      {\n"
 673             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 674             + "        \"pdb_id\":\"3coj\",\n"
 675             + "        \"resolution\":3.21,\n"
 676             + "        \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
 677             + "      {\n"
 678             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 679             + "        \"pdb_id\":\"3pxb\",\n"
 680             + "        \"resolution\":2.5,\n"
 681             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: T1700A\"},\n"
 682             + "      {\n"
 683             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 684             + "        \"pdb_id\":\"1t2u\",\n"
 685             + "        \"resolution\":2.8,\n"
 686             + "        \"title\":\"Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1: structure of BRCA1 missense variant V1809F\"},\n"
 687             + "      {\n"
 688             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 689             + "        \"pdb_id\":\"1n5o\",\n"
 690             + "        \"resolution\":2.8,\n"
 691             + "        \"title\":\"Structural consequences of a cancer-causing BRCA1-BRCT missense mutation\"},\n"
 692             + "      {\n"
 693             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 694             + "        \"pdb_id\":\"4u4a\",\n"
 695             + "        \"resolution\":3.51,\n"
 696             + "        \"title\":\"Complex Structure of BRCA1 BRCT with singly phospho Abraxas\"},\n"
 697             + "      {\n"
 698             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 699             + "        \"pdb_id\":\"4y2g\",\n"
 700             + "        \"resolution\":2.5,\n"
 701             + "        \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas single phosphorylated peptide\"},\n"
 702             + "      {\n"
 703             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 704             + "        \"pdb_id\":\"3pxe\",\n"
 705             + "        \"resolution\":2.85,\n"
 706             + "        \"title\":\"Impact of BRCA1 BRCT domain missense substitutions on phospho-peptide recognition: E1836K\"},\n"
 707             + "      {\n"
 708             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 709             + "        \"pdb_id\":\"4ofb\",\n"
 710             + "        \"resolution\":3.05,\n"
 711             + "        \"title\":\"Crystal structure of human BRCA1 BRCT in complex with nonphosphopeptide inhibitor\"},\n"
 712             + "      {\n"
 713             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 714             + "        \"pdb_id\":\"4y18\",\n"
 715             + "        \"resolution\":3.5,\n"
 716             + "        \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
 717             + "      {\n"
 718             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 719             + "        \"pdb_id\":\"2ing\",\n"
 720             + "        \"resolution\":3.6,\n"
 721             + "        \"title\":\"X-ray Structure of the BRCA1 BRCT mutant M1775K\"},\n"
 722             + "      {\n"
 723             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 724             + "        \"pdb_id\":\"1t29\",\n"
 725             + "        \"resolution\":2.3,\n"
 726             + "        \"title\":\"Crystal structure of the BRCA1 BRCT repeats bound to a phosphorylated BACH1 peptide\"},\n"
 727             + "      {\n"
 728             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 729             + "        \"pdb_id\":\"1t2v\",\n"
 730             + "        \"resolution\":3.3,\n"
 731             + "        \"title\":\"Structural basis of phospho-peptide recognition by the BRCT domain of BRCA1, structure with phosphopeptide\"},\n"
 732             + "      {\n"
 733             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 734             + "        \"pdb_id\":\"1t15\",\n"
 735             + "        \"resolution\":1.85,\n"
 736             + "        \"title\":\"Crystal Structure of the Brca1 BRCT Domains in Complex with the Phosphorylated Interacting Region from Bach1 Helicase\"},\n"
 737             + "      {\n"
 738             + "        \"experimental_method\":[\"Solution NMR\"],\n"
 739             + "        \"pdb_id\":\"1jm7\",\n"
 740             + "        \"title\":\"Solution structure of the BRCA1/BARD1 RING-domain heterodimer\"},\n"
 741             + "      {\n"
 742             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 743             + "        \"pdb_id\":\"4ifi\",\n"
 744             + "        \"resolution\":2.2,\n"
 745             + "        \"title\":\"Structure of human BRCA1 BRCT in complex with BAAT peptide\"},\n"
 746             + "      {\n"
 747             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 748             + "        \"pdb_id\":\"4igk\",\n"
 749             + "        \"resolution\":1.75,\n"
 750             + "        \"title\":\"Structure of human BRCA1 BRCT in complex with ATRIP peptide\"},\n"
 751             + "      {\n"
 752             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 753             + "        \"pdb_id\":\"1y98\",\n"
 754             + "        \"resolution\":2.5,\n"
 755             + "        \"title\":\"Structure of the BRCT repeats of BRCA1 bound to a CtIP phosphopeptide.\"},\n"
 756             + "      {\n"
 757             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 758             + "        \"pdb_id\":\"3k15\",\n"
 759             + "        \"resolution\":2.8,\n"
 760             + "        \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
 761             + "      {\n"
 762             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 763             + "        \"pdb_id\":\"3k0k\",\n"
 764             + "        \"resolution\":2.7,\n"
 765             + "        \"title\":\"Crystal Structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus.\"},\n"
 766             + "      {\n"
 767             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 768             + "        \"pdb_id\":\"3k16\",\n"
 769             + "        \"resolution\":3.0,\n"
 770             + "        \"title\":\"Crystal Structure of BRCA1 BRCT D1840T in complex with a minimal recognition tetrapeptide with a free carboxy C-terminus\"},\n"
 771             + "      {\n"
 772             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 773             + "        \"pdb_id\":\"3k0h\",\n"
 774             + "        \"resolution\":2.7,\n"
 775             + "        \"title\":\"The crystal structure of BRCA1 BRCT in complex with a minimal recognition tetrapeptide with an amidated C-terminus\"},\n"
 776             + "      {\n"
 777             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 778             + "        \"pdb_id\":\"4y18\",\n"
 779             + "        \"resolution\":3.5,\n"
 780             + "        \"title\":\"Structure of BRCA1 BRCT domains in complex with Abraxas double phosphorylated peptide\"},\n"
 781             + "      {\n"
 782             + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 783             + "        \"pdb_id\":\"3coj\",\n"
 784             + "        \"resolution\":3.21,\n"
 785             + "        \"title\":\"Crystal Structure of the BRCT Domains of Human BRCA1 in Complex with a Phosphorylated Peptide from Human Acetyl-CoA Carboxylase 1\"},\n"
 786             + "      {\n"
 787             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 788             + "        \"pdb_id\":\"7jzv\",\n"
 789             + "        \"resolution\":3.9,\n"
 790             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 791             + "      {\n"
 792             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 793             + "        \"pdb_id\":\"7jzv\",\n"
 794             + "        \"resolution\":3.9,\n"
 795             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 796             + "      {\n"
 797             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 798             + "        \"pdb_id\":\"7lyb\",\n"
 799             + "        \"resolution\":3.28,\n"
 800             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 801             + "      {\n"
 802             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 803             + "        \"pdb_id\":\"7lyb\",\n"
 804             + "        \"resolution\":3.28,\n"
 805             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 806             + "      {\n"
 807             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 808             + "        \"pdb_id\":\"7lyb\",\n"
 809             + "        \"resolution\":3.28,\n"
 810             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 811             + "      {\n"
 812             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 813             + "        \"pdb_id\":\"7jzv\",\n"
 814             + "        \"resolution\":3.9,\n"
 815             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 816             + "      {\n"
 817             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 818             + "        \"pdb_id\":\"7lyb\",\n"
 819             + "        \"resolution\":3.28,\n"
 820             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 821             + "      {\n"
 822             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 823             + "        \"pdb_id\":\"7jzv\",\n"
 824             + "        \"resolution\":3.9,\n"
 825             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 826             + "      {\n"
 827             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 828             + "        \"pdb_id\":\"7lyb\",\n"
 829             + "        \"resolution\":3.28,\n"
 830             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 831             + "      {\n"
 832             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 833             + "        \"pdb_id\":\"7jzv\",\n"
 834             + "        \"resolution\":3.9,\n"
 835             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 836             + "      {\n"
 837             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 838             + "        \"pdb_id\":\"7lyb\",\n"
 839             + "        \"resolution\":3.28,\n"
 840             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 841             + "      {\n"
 842             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 843             + "        \"pdb_id\":\"7lyb\",\n"
 844             + "        \"resolution\":3.28,\n"
 845             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 846             + "      {\n"
 847             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 848             + "        \"pdb_id\":\"7lyb\",\n"
 849             + "        \"resolution\":3.28,\n"
 850             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 851             + "      {\n"
 852             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 853             + "        \"pdb_id\":\"7jzv\",\n"
 854             + "        \"resolution\":3.9,\n"
 855             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 856             + "      {\n"
 857             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 858             + "        \"pdb_id\":\"6g2i\",\n"
 859             + "        \"resolution\":5.9,\n"
 860             + "        \"title\":\"Filament of acetyl-CoA carboxylase and BRCT domains of BRCA1 (ACC-BRCT) at 5.9 A resolution\"},\n"
 861             + "      {\n"
 862             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 863             + "        \"pdb_id\":\"7jzv\",\n"
 864             + "        \"resolution\":3.9,\n"
 865             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"},\n"
 866             + "      {\n"
 867             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 868             + "        \"pdb_id\":\"7lyb\",\n"
 869             + "        \"resolution\":3.28,\n"
 870             + "        \"title\":\"Cryo-EM structure of the human nucleosome core particle in complex with BRCA1-BARD1-UbcH5c\"},\n"
 871             + "      {\n"
 872             + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
 873             + "        \"pdb_id\":\"7jzv\",\n"
 874             + "        \"resolution\":3.9,\n"
 875             + "        \"title\":\"Cryo-EM structure of the BRCA1-UbcH5c/BARD1 E3-E2 module bound to a nucleosome\"}]\n"
 876             + "  }}"}
 877     , {
 878       "https://www.ebi.ac.uk/pdbe/search/pdb/select?wt=json&fl=pdb_id,title,experimental_method,resolution&rows=500&start=0&q=(3w7y+OR+3w7y+OR+5e7w+OR+5e7w+OR+5hqi+OR+5hqi+OR+1mso+OR+1mso+OR+3hyd+OR+6ver+OR+6ver+OR+4fka+OR+4fka+OR+3tt8+OR+3tt8+OR+3w7z+OR+3w7z+OR+5usp+OR+5usp+OR+5uoz+OR+5uoz+OR+5urt+OR+5urt+OR+1g7a+OR+4ajx+OR+1g7a+OR+4ajx+OR+5uu2+OR+5uu2+OR+6gv0+OR+6gv0+OR+5hrq+OR+5hrq+OR+1g7b+OR+5usv+OR+3bxq+OR+1g7b+OR+5usv+OR+3bxq+OR+5uqa+OR+5uqa+OR+5hpr+OR+5hpr+OR+5udp+OR+5udp+OR+3fq9+OR+5ena+OR+3exx+OR+6s34+OR+5ena+OR+3exx+OR+6s34+OR+3fq9+OR+6tc2+OR+2omh+OR+2omh+OR+4nib+OR+4cy7+OR+3w80+OR+1ben+OR+7nhu+OR+4nib+OR+4cy7+OR+7nhu+OR+3w80+OR+1ben+OR+6vet+OR+6vet+OR+4ey1+OR+4ey9+OR+4eyd+OR+4ey1+OR+4ey9+OR+4eyd+OR+4xc4+OR+4xc4+OR+1zeh+OR+2wrx+OR+2ws6+OR+2ws6+OR+4cxl+OR+5en9+OR+4p65+OR+2c8r+OR+6s4j+OR+1zeh+OR+2wrx+OR+2ws6+OR+2c8r+OR+4cxl+OR+5en9+OR+4p65+OR+6s4j+OR+6s4i+OR+6s4i+OR+2omg+OR+2omg+OR+4eyn+OR+4eyn+OR+5bqq+OR+5bqq+OR+4exx+OR+5t7r+OR+4exx+OR+5t7r+OR+2wru+OR+2wru+OR+6o17+OR+6o17+OR+4une+OR+4une+OR+4eyp+OR+4f1b+OR+4eyp+OR+4f1b+OR+1zeg+OR+2ws1+OR+3zu1+OR+1trz+OR+4iuz+OR+3i3z+OR+1uz9+OR+3e7y+OR+3i3z+OR+1zeg+OR+2ws1+OR+1uz9+OR+3zu1+OR+3e7y+OR+1trz+OR+4iuz+OR+6tyh+OR+6tyh+OR+6nwv+OR+6nwv+OR+1guj+OR+1guj+OR+4f1d+OR+4f1g+OR+4f4t+OR+4f4v+OR+4f51+OR+4f1d+OR+4f1g+OR+4f4t+OR+4f4v+OR+4f51+OR+4ex1+OR+4ex1+OR+4iyd+OR+4iyd+OR+3utq+OR+4f0o+OR+4f0o+OR+4f8f+OR+4f8f+OR+4f0n+OR+4f0n+OR+5c0d+OR+4f1f+OR+4f1f+OR+3zi3+OR+4f1c+OR+4cxn+OR+5cny+OR+5co2+OR+2oly+OR+2olz+OR+5boq+OR+5viz+OR+3e7z+OR+3zi3+OR+4f1c+OR+4cxn+OR+5cny+OR+3e7z+OR+5co2+OR+2oly+OR+2olz+OR+5boq+OR+5viz+OR+4rxw+OR+4rxw+OR+5bts+OR+5bts+OR+4gbc+OR+4gbc+OR+1ev3+OR+1ev3+OR+4ewz+OR+4ewz+OR+4f1a+OR+2vjz+OR+1rwe+OR+5co6+OR+6p4z+OR+1xda+OR+4ajz+OR+4iyf+OR+2ceu+OR+4f1a+OR+2ceu+OR+2vjz+OR+1rwe+OR+1xda+OR+5co6+OR+4ajz+OR+6p4z+OR+4iyf+OR+4ung+OR+4ung+OR+6h3m+OR+6h3m+OR+3inc+OR+3i40+OR+6ves+OR+3i40+OR+6ves+OR+3inc+OR+4z77+OR+4ex0+OR+4ex0+OR+4gbn+OR+4gbn+OR+5mt9+OR+5mt9+OR+4z76+OR+3ilg+OR+3zqr+OR+3kq6+OR+1ev6+OR+1evr+OR+1tyl+OR+1tym+OR+5bpo+OR+1htv+OR+2ws4+OR+1htv+OR+2ws4+OR+3ilg+OR+3zqr+OR+3kq6+OR+1ev6+OR+1evr+OR+1tyl+OR+1tym+OR+5bpo+OR+5co9+OR+5co9+OR+1os3+OR+2c8q+OR+2c8q+OR+1os3+OR+2om1+OR+3zs2+OR+2om1+OR+3zs2+OR+5uu4+OR+5uu4+OR+3u4n+OR+4efx+OR+3u4n+OR+4efx+OR+1q4v+OR+3p2x+OR+2qiu+OR+3v19+OR+1j73+OR+1qiz+OR+1znj+OR+2r36+OR+2w44+OR+2qiu+OR+2r36+OR+1q4v+OR+3p2x+OR+3v19+OR+1j73+OR+1qiz+OR+1znj+OR+2w44+OR+2omq+OR+4fg3+OR+4fg3+OR+4akj+OR+4akj+OR+5mt3+OR+5mt3+OR+2om0+OR+3q6e+OR+2om0+OR+3q6e+OR+5uss+OR+5uss+OR+1w8p+OR+2r35+OR+2r35+OR+1w8p+OR+2ws0+OR+2ws0+OR+2wrv+OR+2wrv+OR+6z7y+OR+5mam+OR+3v1g+OR+2vk0+OR+3ir0+OR+5hpu+OR+2g56+OR+6gnq+OR+6z7y+OR+5mam+OR+3v1g+OR+2vk0+OR+3ir0+OR+5hpu+OR+6gnq+OR+4ewx+OR+4ewx+OR+2omi+OR+2omi+OR+5uu3+OR+1os4+OR+2g54+OR+6ck2+OR+2r34+OR+2r34+OR+5uu3+OR+1os4+OR+6ck2+OR+4ak0+OR+4ak0+OR+3p33+OR+5ems+OR+1qiy+OR+1lph+OR+3rov+OR+4eww+OR+1xw7+OR+3p33+OR+5ems+OR+1qiy+OR+1lph+OR+3rov+OR+4eww+OR+1xw7+OR+4z78+OR+4wdi+OR+1qj0+OR+4gbk+OR+1qj0+OR+4gbk+OR+1jk8+OR+5uru+OR+2wrw+OR+2wrw+OR+5uru+OR+6z7w+OR+6z7w+OR+1jca+OR+3jsd+OR+1b9e+OR+4gbl+OR+1jca+OR+3jsd+OR+1b9e+OR+4gbl+OR+4y19+OR+4gbi+OR+4gbi+OR+2ws7+OR+2ws7+OR+2wby+OR+2wby+OR+3utt+OR+3uts+OR+4unh+OR+4unh+OR+2wc0+OR+2wc0+OR+5wdm+OR+6vep+OR+6vep+OR+5hyj+OR+6hn5+OR+6hn5+OR+5cjo+OR+4oga+OR+4oga+OR+6b70+OR+6b3q+OR+6bfc+OR+7bw8+OR+3w11+OR+3w11+OR+5wob+OR+4y1a+OR+7bw7+OR+6sof+OR+6ce9+OR+6sof+OR+3w12+OR+3w12+OR+3w13+OR+3w13+OR+6jk8+OR+6ceb+OR+7bwa+OR+6ce7+OR+6jr3+OR+6jr3+OR+2kqp+OR+1efe+OR+6u46+OR+1sju+OR+5mwq+OR+6k59+OR+1t0c+OR+5mhd+OR+2lgb+OR+2mvd+OR+2mvc+OR+1k3m+OR+2juu+OR+1hiq+OR+2juv+OR+2rn5+OR+2kxk+OR+2hiu+OR+2l1y+OR+2l1z+OR+2kju+OR+1xgl+OR+1jco+OR+2jv1+OR+2kqq+OR+1fu2+OR+1kmf+OR+1vkt+OR+1fub+OR+2n2x+OR+2n2v+OR+2n2w+OR+1t1k+OR+1t1p+OR+1t1q+OR+2mpg+OR+1sf1+OR+2mpi+OR+2jmn+OR+2k9r+OR+6x4x+OR+1lkq+OR+2m1d+OR+2m1e+OR+2mli+OR+2hh4+OR+2m2m+OR+2aiy+OR+1hit+OR+2hho+OR+1hls+OR+2m2n+OR+2m2o+OR+2m2p+OR+3aiy+OR+4aiy+OR+5aiy+OR+2kjj+OR+2k91+OR+1ai0+OR+1aiy+OR+2h67+OR+1mhi+OR+2jum+OR+1sjt+OR+1a7f+OR+1iog+OR+1ioh+OR+1mhj+OR+1hui+OR+1his+OR+2mvc+OR+2mvd+OR+1k3m+OR+2juu+OR+1hiq+OR+2juv+OR+2rn5+OR+2kxk+OR+2hiu+OR+2l1z+OR+2l1y+OR+1sjt+OR+2kju+OR+1xgl+OR+1jco+OR+2jv1+OR+1a7f+OR+1iog+OR+1ioh+OR+2kqq+OR+1fu2+OR+1kmf+OR+1vkt+OR+1fub+OR+2n2v+OR+2n2w+OR+2n2x+OR+1t1k+OR+1t1p+OR+1t1q+OR+2mpg+OR+1sf1+OR+5mwq+OR+2mpi+OR+2jmn+OR+2k9r+OR+6x4x+OR+5mhd+OR+1lkq+OR+2lgb+OR+2m1d+OR+2m1e+OR+2mli+OR+2hh4+OR+2m2m+OR+2aiy+OR+1his+OR+1hit+OR+2hho+OR+1hls+OR+2m2n+OR+2m2o+OR+2m2p+OR+3aiy+OR+4aiy+OR+5aiy+OR+1hui+OR+2kjj+OR+2k91+OR+1ai0+OR+1aiy+OR+2h67+OR+1mhi+OR+1mhj+OR+2jum+OR+6k59)+AND+molecule_sequence:%5B''+TO+*%5D+AND+status:REL&sort="
 879       , "{\n"
 880               + "  \"responseHeader\":{\n"
 881               + "    \"status\":0,\n"
 882               + "    \"QTime\":6,\n"
 883               + "    \"params\":{\n"
 884               + "      \"q\":\"(3w7y OR 3w7y OR 5e7w OR 5e7w OR 5hqi OR 5hqi OR 1mso OR 1mso OR 3hyd OR 6ver OR 6ver OR 4fka OR 4fka OR 3tt8 OR 3tt8 OR 3w7z OR 3w7z OR 5usp OR 5usp OR 5uoz OR 5uoz OR 5urt OR 5urt OR 1g7a OR 4ajx OR 1g7a OR 4ajx OR 5uu2 OR 5uu2 OR 6gv0 OR 6gv0 OR 5hrq OR 5hrq OR 1g7b OR 5usv OR 3bxq OR 1g7b OR 5usv OR 3bxq OR 5uqa OR 5uqa OR 5hpr OR 5hpr OR 5udp OR 5udp OR 3fq9 OR 5ena OR 3exx OR 6s34 OR 5ena OR 3exx OR 6s34 OR 3fq9 OR 6tc2 OR 2omh OR 2omh OR 4nib OR 4cy7 OR 3w80 OR 1ben OR 7nhu OR 4nib OR 4cy7 OR 7nhu OR 3w80 OR 1ben OR 6vet OR 6vet OR 4ey1 OR 4ey9 OR 4eyd OR 4ey1 OR 4ey9 OR 4eyd OR 4xc4 OR 4xc4 OR 1zeh OR 2wrx OR 2ws6 OR 2ws6 OR 4cxl OR 5en9 OR 4p65 OR 2c8r OR 6s4j OR 1zeh OR 2wrx OR 2ws6 OR 2c8r OR 4cxl OR 5en9 OR 4p65 OR 6s4j OR 6s4i OR 6s4i OR 2omg OR 2omg OR 4eyn OR 4eyn OR 5bqq OR 5bqq OR 4exx OR 5t7r OR 4exx OR 5t7r OR 2wru OR 2wru OR 6o17 OR 6o17 OR 4une OR 4une OR 4eyp OR 4f1b OR 4eyp OR 4f1b OR 1zeg OR 2ws1 OR 3zu1 OR 1trz OR 4iuz OR 3i3z OR 1uz9 OR 3e7y OR 3i3z OR 1zeg OR 2ws1 OR 1uz9 OR 3zu1 OR 3e7y OR 1trz OR 4iuz OR 6tyh OR 6tyh OR 6nwv OR 6nwv OR 1guj OR 1guj OR 4f1d OR 4f1g OR 4f4t OR 4f4v OR 4f51 OR 4f1d OR 4f1g OR 4f4t OR 4f4v OR 4f51 OR 4ex1 OR 4ex1 OR 4iyd OR 4iyd OR 3utq OR 4f0o OR 4f0o OR 4f8f OR 4f8f OR 4f0n OR 4f0n OR 5c0d OR 4f1f OR 4f1f OR 3zi3 OR 4f1c OR 4cxn OR 5cny OR 5co2 OR 2oly OR 2olz OR 5boq OR 5viz OR 3e7z OR 3zi3 OR 4f1c OR 4cxn OR 5cny OR 3e7z OR 5co2 OR 2oly OR 2olz OR 5boq OR 5viz OR 4rxw OR 4rxw OR 5bts OR 5bts OR 4gbc OR 4gbc OR 1ev3 OR 1ev3 OR 4ewz OR 4ewz OR 4f1a OR 2vjz OR 1rwe OR 5co6 OR 6p4z OR 1xda OR 4ajz OR 4iyf OR 2ceu OR 4f1a OR 2ceu OR 2vjz OR 1rwe OR 1xda OR 5co6 OR 4ajz OR 6p4z OR 4iyf OR 4ung OR 4ung OR 6h3m OR 6h3m OR 3inc OR 3i40 OR 6ves OR 3i40 OR 6ves OR 3inc OR 4z77 OR 4ex0 OR 4ex0 OR 4gbn OR 4gbn OR 5mt9 OR 5mt9 OR 4z76 OR 3ilg OR 3zqr OR 3kq6 OR 1ev6 OR 1evr OR 1tyl OR 1tym OR 5bpo OR 1htv OR 2ws4 OR 1htv OR 2ws4 OR 3ilg OR 3zqr OR 3kq6 OR 1ev6 OR 1evr OR 1tyl OR 1tym OR 5bpo OR 5co9 OR 5co9 OR 1os3 OR 2c8q OR 2c8q OR 1os3 OR 2om1 OR 3zs2 OR 2om1 OR 3zs2 OR 5uu4 OR 5uu4 OR 3u4n OR 4efx OR 3u4n OR 4efx OR 1q4v OR 3p2x OR 2qiu OR 3v19 OR 1j73 OR 1qiz OR 1znj OR 2r36 OR 2w44 OR 2qiu OR 2r36 OR 1q4v OR 3p2x OR 3v19 OR 1j73 OR 1qiz OR 1znj OR 2w44 OR 2omq OR 4fg3 OR 4fg3 OR 4akj OR 4akj OR 5mt3 OR 5mt3 OR 2om0 OR 3q6e OR 2om0 OR 3q6e OR 5uss OR 5uss OR 1w8p OR 2r35 OR 2r35 OR 1w8p OR 2ws0 OR 2ws0 OR 2wrv OR 2wrv OR 6z7y OR 5mam OR 3v1g OR 2vk0 OR 3ir0 OR 5hpu OR 2g56 OR 6gnq OR 6z7y OR 5mam OR 3v1g OR 2vk0 OR 3ir0 OR 5hpu OR 6gnq OR 4ewx OR 4ewx OR 2omi OR 2omi OR 5uu3 OR 1os4 OR 2g54 OR 6ck2 OR 2r34 OR 2r34 OR 5uu3 OR 1os4 OR 6ck2 OR 4ak0 OR 4ak0 OR 3p33 OR 5ems OR 1qiy OR 1lph OR 3rov OR 4eww OR 1xw7 OR 3p33 OR 5ems OR 1qiy OR 1lph OR 3rov OR 4eww OR 1xw7 OR 4z78 OR 4wdi OR 1qj0 OR 4gbk OR 1qj0 OR 4gbk OR 1jk8 OR 5uru OR 2wrw OR 2wrw OR 5uru OR 6z7w OR 6z7w OR 1jca OR 3jsd OR 1b9e OR 4gbl OR 1jca OR 3jsd OR 1b9e OR 4gbl OR 4y19 OR 4gbi OR 4gbi OR 2ws7 OR 2ws7 OR 2wby OR 2wby OR 3utt OR 3uts OR 4unh OR 4unh OR 2wc0 OR 2wc0 OR 5wdm OR 6vep OR 6vep OR 5hyj OR 6hn5 OR 6hn5 OR 5cjo OR 4oga OR 4oga OR 6b70 OR 6b3q OR 6bfc OR 7bw8 OR 3w11 OR 3w11 OR 5wob OR 4y1a OR 7bw7 OR 6sof OR 6ce9 OR 6sof OR 3w12 OR 3w12 OR 3w13 OR 3w13 OR 6jk8 OR 6ceb OR 7bwa OR 6ce7 OR 6jr3 OR 6jr3 OR 2kqp OR 1efe OR 6u46 OR 1sju OR 5mwq OR 6k59 OR 1t0c OR 5mhd OR 2lgb OR 2mvd OR 2mvc OR 1k3m OR 2juu OR 1hiq OR 2juv OR 2rn5 OR 2kxk OR 2hiu OR 2l1y OR 2l1z OR 2kju OR 1xgl OR 1jco OR 2jv1 OR 2kqq OR 1fu2 OR 1kmf OR 1vkt OR 1fub OR 2n2x OR 2n2v OR 2n2w OR 1t1k OR 1t1p OR 1t1q OR 2mpg OR 1sf1 OR 2mpi OR 2jmn OR 2k9r OR 6x4x OR 1lkq OR 2m1d OR 2m1e OR 2mli OR 2hh4 OR 2m2m OR 2aiy OR 1hit OR 2hho OR 1hls OR 2m2n OR 2m2o OR 2m2p OR 3aiy OR 4aiy OR 5aiy OR 2kjj OR 2k91 OR 1ai0 OR 1aiy OR 2h67 OR 1mhi OR 2jum OR 1sjt OR 1a7f OR 1iog OR 1ioh OR 1mhj OR 1hui OR 1his OR 2mvc OR 2mvd OR 1k3m OR 2juu OR 1hiq OR 2juv OR 2rn5 OR 2kxk OR 2hiu OR 2l1z OR 2l1y OR 1sjt OR 2kju OR 1xgl OR 1jco OR 2jv1 OR 1a7f OR 1iog OR 1ioh OR 2kqq OR 1fu2 OR 1kmf OR 1vkt OR 1fub OR 2n2v OR 2n2w OR 2n2x OR 1t1k OR 1t1p OR 1t1q OR 2mpg OR 1sf1 OR 5mwq OR 2mpi OR 2jmn OR 2k9r OR 6x4x OR 5mhd OR 1lkq OR 2lgb OR 2m1d OR 2m1e OR 2mli OR 2hh4 OR 2m2m OR 2aiy OR 1his OR 1hit OR 2hho OR 1hls OR 2m2n OR 2m2o OR 2m2p OR 3aiy OR 4aiy OR 5aiy OR 1hui OR 2kjj OR 2k91 OR 1ai0 OR 1aiy OR 2h67 OR 1mhi OR 1mhj OR 2jum OR 6k59) AND molecule_sequence:['' TO *] AND status:REL\",\n"
 885               + "      \"fl\":\"pdb_id,title,experimental_method,resolution\",\n"
 886               + "      \"start\":\"0\",\n"
 887               + "      \"sort\":\"\",\n"
 888               + "      \"rows\":\"500\",\n"
 889               + "      \"wt\":\"json\"}},\n"
 890               + "  \"response\":{\"numFound\":638,\"start\":0,\"docs\":[\n"
 891               + "      {\n"
 892               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 893               + "        \"pdb_id\":\"2ws6\",\n"
 894               + "        \"resolution\":1.5,\n"
 895               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form\"},\n"
 896               + "      {\n"
 897               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 898               + "        \"pdb_id\":\"2ws6\",\n"
 899               + "        \"resolution\":1.5,\n"
 900               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form\"},\n"
 901               + "      {\n"
 902               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 903               + "        \"pdb_id\":\"2ws6\",\n"
 904               + "        \"resolution\":1.5,\n"
 905               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form\"},\n"
 906               + "      {\n"
 907               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 908               + "        \"pdb_id\":\"1hit\",\n"
 909               + "        \"title\":\"Receptor binding redefined by a structural switch in a mutant Human Insulin\"},\n"
 910               + "      {\n"
 911               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 912               + "        \"pdb_id\":\"1his\",\n"
 913               + "        \"title\":\"Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis.\"},\n"
 914               + "      {\n"
 915               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 916               + "        \"pdb_id\":\"1his\",\n"
 917               + "        \"title\":\"Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis.\"},\n"
 918               + "      {\n"
 919               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 920               + "        \"pdb_id\":\"6k59\",\n"
 921               + "        \"title\":\"Structure of Glargine insulin in 20% acetic acid-d4 (pH 1.9)\"},\n"
 922               + "      {\n"
 923               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 924               + "        \"pdb_id\":\"6k59\",\n"
 925               + "        \"title\":\"Structure of Glargine insulin in 20% acetic acid-d4 (pH 1.9)\"},\n"
 926               + "      {\n"
 927               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 928               + "        \"pdb_id\":\"1hit\",\n"
 929               + "        \"title\":\"Receptor binding redefined by a structural switch in a mutant Human Insulin\"},\n"
 930               + "      {\n"
 931               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 932               + "        \"pdb_id\":\"2m2o\",\n"
 933               + "        \"title\":\"Structure of [D-HisB24] insulin analogue at pH 1.9\"},\n"
 934               + "      {\n"
 935               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 936               + "        \"pdb_id\":\"2m1d\",\n"
 937               + "        \"title\":\"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions.\"},\n"
 938               + "      {\n"
 939               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 940               + "        \"pdb_id\":\"2m2n\",\n"
 941               + "        \"title\":\"Structure of [L-HisB24] insulin analogue at pH 8.0\"},\n"
 942               + "      {\n"
 943               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 944               + "        \"pdb_id\":\"2m2n\",\n"
 945               + "        \"title\":\"Structure of [L-HisB24] insulin analogue at pH 8.0\"},\n"
 946               + "      {\n"
 947               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 948               + "        \"pdb_id\":\"1sjt\",\n"
 949               + "        \"title\":\"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES\"},\n"
 950               + "      {\n"
 951               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 952               + "        \"pdb_id\":\"1vkt\",\n"
 953               + "        \"title\":\"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES\"},\n"
 954               + "      {\n"
 955               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 956               + "        \"pdb_id\":\"2c8r\",\n"
 957               + "        \"resolution\":1.5,\n"
 958               + "        \"title\":\"insuline(60sec) and UV laser excited fluorescence\"},\n"
 959               + "      {\n"
 960               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 961               + "        \"pdb_id\":\"2c8r\",\n"
 962               + "        \"resolution\":1.5,\n"
 963               + "        \"title\":\"insuline(60sec) and UV laser excited fluorescence\"},\n"
 964               + "      {\n"
 965               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 966               + "        \"pdb_id\":\"1hiq\",\n"
 967               + "        \"title\":\"PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS\"},\n"
 968               + "      {\n"
 969               + "        \"experimental_method\":[\"Solution NMR\"],\n"
 970               + "        \"pdb_id\":\"1hiq\",\n"
 971               + "        \"title\":\"PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS\"},\n"
 972               + "      {\n"
 973               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 974               + "        \"pdb_id\":\"2c8q\",\n"
 975               + "        \"resolution\":1.95,\n"
 976               + "        \"title\":\"insuline(1sec) and UV laser excited fluorescence\"},\n"
 977               + "      {\n"
 978               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 979               + "        \"pdb_id\":\"2c8q\",\n"
 980               + "        \"resolution\":1.95,\n"
 981               + "        \"title\":\"insuline(1sec) and UV laser excited fluorescence\"},\n"
 982               + "      {\n"
 983               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 984               + "        \"pdb_id\":\"6o17\",\n"
 985               + "        \"resolution\":1.58,\n"
 986               + "        \"title\":\"Recombinant Human Insulin\"},\n"
 987               + "      {\n"
 988               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 989               + "        \"pdb_id\":\"6o17\",\n"
 990               + "        \"resolution\":1.58,\n"
 991               + "        \"title\":\"Recombinant Human Insulin\"},\n"
 992               + "      {\n"
 993               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 994               + "        \"pdb_id\":\"7nhu\",\n"
 995               + "        \"resolution\":1.4,\n"
 996               + "        \"title\":\"Crystal structure of desB30 insulin produced by cell free protein synthesis\"},\n"
 997               + "      {\n"
 998               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
 999               + "        \"pdb_id\":\"7nhu\",\n"
1000               + "        \"resolution\":1.4,\n"
1001               + "        \"title\":\"Crystal structure of desB30 insulin produced by cell free protein synthesis\"},\n"
1002               + "      {\n"
1003               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1004               + "        \"pdb_id\":\"2mvd\",\n"
1005               + "        \"title\":\"Solution structure of [GlnB22]-insulin mutant at pH 1.9\"},\n"
1006               + "      {\n"
1007               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1008               + "        \"pdb_id\":\"2mvd\",\n"
1009               + "        \"title\":\"Solution structure of [GlnB22]-insulin mutant at pH 1.9\"},\n"
1010               + "      {\n"
1011               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1012               + "        \"pdb_id\":\"2mvc\",\n"
1013               + "        \"title\":\"Solution structure of human insulin at pH 1.9\"},\n"
1014               + "      {\n"
1015               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1016               + "        \"pdb_id\":\"2m1e\",\n"
1017               + "        \"title\":\"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions.\"},\n"
1018               + "      {\n"
1019               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1020               + "        \"pdb_id\":\"2m2p\",\n"
1021               + "        \"title\":\"Structure of [D-HisB24] insulin analogue at pH 8.0\"},\n"
1022               + "      {\n"
1023               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1024               + "        \"pdb_id\":\"2ws4\",\n"
1025               + "        \"resolution\":1.9,\n"
1026               + "        \"title\":\"Semi-synthetic analogue of human insulin ProB26-DTI in monomer form\"},\n"
1027               + "      {\n"
1028               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1029               + "        \"pdb_id\":\"2m2o\",\n"
1030               + "        \"title\":\"Structure of [D-HisB24] insulin analogue at pH 1.9\"},\n"
1031               + "      {\n"
1032               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1033               + "        \"pdb_id\":\"2m1d\",\n"
1034               + "        \"title\":\"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solutions.\"},\n"
1035               + "      {\n"
1036               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1037               + "        \"pdb_id\":\"2m1e\",\n"
1038               + "        \"title\":\"Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions.\"},\n"
1039               + "      {\n"
1040               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1041               + "        \"pdb_id\":\"1sjt\",\n"
1042               + "        \"title\":\"MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRUCTURES\"},\n"
1043               + "      {\n"
1044               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1045               + "        \"pdb_id\":\"1vkt\",\n"
1046               + "        \"title\":\"HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES\"},\n"
1047               + "      {\n"
1048               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1049               + "        \"pdb_id\":\"3ilg\",\n"
1050               + "        \"resolution\":1.9,\n"
1051               + "        \"title\":\"Crystal structure of humnan insulin Sr+2 complex\"},\n"
1052               + "      {\n"
1053               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1054               + "        \"pdb_id\":\"1lkq\",\n"
1055               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES\"},\n"
1056               + "      {\n"
1057               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1058               + "        \"pdb_id\":\"1k3m\",\n"
1059               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1060               + "      {\n"
1061               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1062               + "        \"pdb_id\":\"1k3m\",\n"
1063               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1064               + "      {\n"
1065               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1066               + "        \"pdb_id\":\"1lkq\",\n"
1067               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 STRUCTURES\"},\n"
1068               + "      {\n"
1069               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1070               + "        \"pdb_id\":\"5mwq\",\n"
1071               + "        \"title\":\"Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile solution\"},\n"
1072               + "      {\n"
1073               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1074               + "        \"pdb_id\":\"5ena\",\n"
1075               + "        \"resolution\":1.35,\n"
1076               + "        \"title\":\"Xray crystal structure of isotope-labeled human insulin\"},\n"
1077               + "      {\n"
1078               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1079               + "        \"pdb_id\":\"5viz\",\n"
1080               + "        \"resolution\":1.7,\n"
1081               + "        \"title\":\"X-Ray structure of Insulin Glargine\"},\n"
1082               + "      {\n"
1083               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1084               + "        \"pdb_id\":\"5viz\",\n"
1085               + "        \"resolution\":1.7,\n"
1086               + "        \"title\":\"X-Ray structure of Insulin Glargine\"},\n"
1087               + "      {\n"
1088               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1089               + "        \"pdb_id\":\"2mvc\",\n"
1090               + "        \"title\":\"Solution structure of human insulin at pH 1.9\"},\n"
1091               + "      {\n"
1092               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1093               + "        \"pdb_id\":\"5en9\",\n"
1094               + "        \"resolution\":1.5,\n"
1095               + "        \"title\":\"High resolution x-ray crystal structure of isotope-labeled ester-insulin\"},\n"
1096               + "      {\n"
1097               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1098               + "        \"pdb_id\":\"2m2p\",\n"
1099               + "        \"title\":\"Structure of [D-HisB24] insulin analogue at pH 8.0\"},\n"
1100               + "      {\n"
1101               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1102               + "        \"pdb_id\":\"2jum\",\n"
1103               + "        \"title\":\"ThrA3-DKP-insulin\"},\n"
1104               + "      {\n"
1105               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1106               + "        \"pdb_id\":\"2jum\",\n"
1107               + "        \"title\":\"ThrA3-DKP-insulin\"},\n"
1108               + "      {\n"
1109               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1110               + "        \"pdb_id\":\"2kjj\",\n"
1111               + "        \"title\":\"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface\"},\n"
1112               + "      {\n"
1113               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1114               + "        \"pdb_id\":\"2kjj\",\n"
1115               + "        \"title\":\"Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-binding surface\"},\n"
1116               + "      {\n"
1117               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1118               + "        \"pdb_id\":\"2jv1\",\n"
1119               + "        \"title\":\"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures\"},\n"
1120               + "      {\n"
1121               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1122               + "        \"pdb_id\":\"2kju\",\n"
1123               + "        \"title\":\"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures\"},\n"
1124               + "      {\n"
1125               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1126               + "        \"pdb_id\":\"2juu\",\n"
1127               + "        \"title\":\"allo-ThrA3 DKP-insulin\"},\n"
1128               + "      {\n"
1129               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1130               + "        \"pdb_id\":\"2wrw\",\n"
1131               + "        \"resolution\":2.41,\n"
1132               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2\"},\n"
1133               + "      {\n"
1134               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1135               + "        \"pdb_id\":\"2wrw\",\n"
1136               + "        \"resolution\":2.41,\n"
1137               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2\"},\n"
1138               + "      {\n"
1139               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1140               + "        \"pdb_id\":\"2ws4\",\n"
1141               + "        \"resolution\":1.9,\n"
1142               + "        \"title\":\"Semi-synthetic analogue of human insulin ProB26-DTI in monomer form\"},\n"
1143               + "      {\n"
1144               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1145               + "        \"pdb_id\":\"2r34\",\n"
1146               + "        \"resolution\":2.25,\n"
1147               + "        \"title\":\"Crystal structure of MN human arg-insulin\"},\n"
1148               + "      {\n"
1149               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1150               + "        \"pdb_id\":\"2l1z\",\n"
1151               + "        \"title\":\"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures\"},\n"
1152               + "      {\n"
1153               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1154               + "        \"pdb_id\":\"2l1z\",\n"
1155               + "        \"title\":\"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures\"},\n"
1156               + "      {\n"
1157               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1158               + "        \"pdb_id\":\"2qiu\",\n"
1159               + "        \"resolution\":2.0,\n"
1160               + "        \"title\":\"Structure of Human Arg-Insulin\"},\n"
1161               + "      {\n"
1162               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1163               + "        \"pdb_id\":\"1os4\",\n"
1164               + "        \"resolution\":2.25,\n"
1165               + "        \"title\":\"Dehydrated T6 human insulin at 295 K\"},\n"
1166               + "      {\n"
1167               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1168               + "        \"pdb_id\":\"1t1k\",\n"
1169               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1170               + "      {\n"
1171               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1172               + "        \"pdb_id\":\"1t1k\",\n"
1173               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1174               + "      {\n"
1175               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1176               + "        \"pdb_id\":\"3ilg\",\n"
1177               + "        \"resolution\":1.9,\n"
1178               + "        \"title\":\"Crystal structure of humnan insulin Sr+2 complex\"},\n"
1179               + "      {\n"
1180               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1181               + "        \"pdb_id\":\"3i40\",\n"
1182               + "        \"resolution\":1.85,\n"
1183               + "        \"title\":\"Human insulin\"},\n"
1184               + "      {\n"
1185               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1186               + "        \"pdb_id\":\"1xgl\",\n"
1187               + "        \"title\":\"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES\"},\n"
1188               + "      {\n"
1189               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1190               + "        \"pdb_id\":\"1xgl\",\n"
1191               + "        \"title\":\"HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES\"},\n"
1192               + "      {\n"
1193               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1194               + "        \"pdb_id\":\"1iog\",\n"
1195               + "        \"title\":\"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES\"},\n"
1196               + "      {\n"
1197               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1198               + "        \"pdb_id\":\"1jco\",\n"
1199               + "        \"title\":\"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)\"},\n"
1200               + "      {\n"
1201               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1202               + "        \"pdb_id\":\"1kmf\",\n"
1203               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1204               + "      {\n"
1205               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1206               + "        \"pdb_id\":\"1kmf\",\n"
1207               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1208               + "      {\n"
1209               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1210               + "        \"pdb_id\":\"1hui\",\n"
1211               + "        \"title\":\"INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES\"},\n"
1212               + "      {\n"
1213               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1214               + "        \"pdb_id\":\"1hui\",\n"
1215               + "        \"title\":\"INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES\"},\n"
1216               + "      {\n"
1217               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1218               + "        \"pdb_id\":\"1a7f\",\n"
1219               + "        \"title\":\"INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES\"},\n"
1220               + "      {\n"
1221               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1222               + "        \"pdb_id\":\"1ioh\",\n"
1223               + "        \"title\":\"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES\"},\n"
1224               + "      {\n"
1225               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
1226               + "        \"pdb_id\":\"6jr3\",\n"
1227               + "        \"resolution\":14.5,\n"
1228               + "        \"title\":\"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body\"},\n"
1229               + "      {\n"
1230               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
1231               + "        \"pdb_id\":\"6jr3\",\n"
1232               + "        \"resolution\":14.5,\n"
1233               + "        \"title\":\"Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as rigid body\"},\n"
1234               + "      {\n"
1235               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1236               + "        \"pdb_id\":\"5mwq\",\n"
1237               + "        \"title\":\"Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile solution\"},\n"
1238               + "      {\n"
1239               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1240               + "        \"pdb_id\":\"6x4x\",\n"
1241               + "        \"title\":\"B24Y DKP insulin\"},\n"
1242               + "      {\n"
1243               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1244               + "        \"pdb_id\":\"6x4x\",\n"
1245               + "        \"title\":\"B24Y DKP insulin\"},\n"
1246               + "      {\n"
1247               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1248               + "        \"pdb_id\":\"5t7r\",\n"
1249               + "        \"resolution\":1.55,\n"
1250               + "        \"title\":\"A6-A11 trans-dicarba human insulin\"},\n"
1251               + "      {\n"
1252               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1253               + "        \"pdb_id\":\"5t7r\",\n"
1254               + "        \"resolution\":1.55,\n"
1255               + "        \"title\":\"A6-A11 trans-dicarba human insulin\"},\n"
1256               + "      {\n"
1257               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1258               + "        \"pdb_id\":\"5ena\",\n"
1259               + "        \"resolution\":1.35,\n"
1260               + "        \"title\":\"Xray crystal structure of isotope-labeled human insulin\"},\n"
1261               + "      {\n"
1262               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1263               + "        \"pdb_id\":\"3zi3\",\n"
1264               + "        \"resolution\":1.7,\n"
1265               + "        \"title\":\"Crystal structure of the B24His-insulin - human analogue\"},\n"
1266               + "      {\n"
1267               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1268               + "        \"pdb_id\":\"3zi3\",\n"
1269               + "        \"resolution\":1.7,\n"
1270               + "        \"title\":\"Crystal structure of the B24His-insulin - human analogue\"},\n"
1271               + "      {\n"
1272               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1273               + "        \"pdb_id\":\"3u4n\",\n"
1274               + "        \"resolution\":1.98,\n"
1275               + "        \"title\":\"A novel covalently linked insulin dimer\"},\n"
1276               + "      {\n"
1277               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1278               + "        \"pdb_id\":\"3u4n\",\n"
1279               + "        \"resolution\":1.98,\n"
1280               + "        \"title\":\"A novel covalently linked insulin dimer\"},\n"
1281               + "      {\n"
1282               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1283               + "        \"pdb_id\":\"2r35\",\n"
1284               + "        \"resolution\":2.08,\n"
1285               + "        \"title\":\"Crystal structure of RB human arg-insulin\"},\n"
1286               + "      {\n"
1287               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1288               + "        \"pdb_id\":\"5en9\",\n"
1289               + "        \"resolution\":1.5,\n"
1290               + "        \"title\":\"High resolution x-ray crystal structure of isotope-labeled ester-insulin\"},\n"
1291               + "      {\n"
1292               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1293               + "        \"pdb_id\":\"2h67\",\n"
1294               + "        \"title\":\"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1295               + "      {\n"
1296               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1297               + "        \"pdb_id\":\"2kju\",\n"
1298               + "        \"title\":\"NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 structures\"},\n"
1299               + "      {\n"
1300               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1301               + "        \"pdb_id\":\"2hho\",\n"
1302               + "        \"title\":\"NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1303               + "      {\n"
1304               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1305               + "        \"pdb_id\":\"2juv\",\n"
1306               + "        \"title\":\"AbaA3-DKP-insulin\"},\n"
1307               + "      {\n"
1308               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1309               + "        \"pdb_id\":\"2juv\",\n"
1310               + "        \"title\":\"AbaA3-DKP-insulin\"},\n"
1311               + "      {\n"
1312               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1313               + "        \"pdb_id\":\"2jv1\",\n"
1314               + "        \"title\":\"NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures\"},\n"
1315               + "      {\n"
1316               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1317               + "        \"pdb_id\":\"2juu\",\n"
1318               + "        \"title\":\"allo-ThrA3 DKP-insulin\"},\n"
1319               + "      {\n"
1320               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1321               + "        \"pdb_id\":\"2h67\",\n"
1322               + "        \"title\":\"NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1323               + "      {\n"
1324               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1325               + "        \"pdb_id\":\"2ws0\",\n"
1326               + "        \"resolution\":2.1,\n"
1327               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5\"},\n"
1328               + "      {\n"
1329               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1330               + "        \"pdb_id\":\"2rn5\",\n"
1331               + "        \"title\":\"Humal Insulin Mutant B31Lys-B32Arg\"},\n"
1332               + "      {\n"
1333               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1334               + "        \"pdb_id\":\"2rn5\",\n"
1335               + "        \"title\":\"Humal Insulin Mutant B31Lys-B32Arg\"},\n"
1336               + "      {\n"
1337               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1338               + "        \"pdb_id\":\"2qiu\",\n"
1339               + "        \"resolution\":2.0,\n"
1340               + "        \"title\":\"Structure of Human Arg-Insulin\"},\n"
1341               + "      {\n"
1342               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1343               + "        \"pdb_id\":\"2lgb\",\n"
1344               + "        \"title\":\"Modified A22Gly-B31Arg Human Insulin\"},\n"
1345               + "      {\n"
1346               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1347               + "        \"pdb_id\":\"2lgb\",\n"
1348               + "        \"title\":\"Modified A22Gly-B31Arg Human Insulin\"},\n"
1349               + "      {\n"
1350               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1351               + "        \"pdb_id\":\"1os4\",\n"
1352               + "        \"resolution\":2.25,\n"
1353               + "        \"title\":\"Dehydrated T6 human insulin at 295 K\"},\n"
1354               + "      {\n"
1355               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1356               + "        \"pdb_id\":\"1t1p\",\n"
1357               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1358               + "      {\n"
1359               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1360               + "        \"pdb_id\":\"1t1p\",\n"
1361               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1362               + "      {\n"
1363               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1364               + "        \"pdb_id\":\"2aiy\",\n"
1365               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES\"},\n"
1366               + "      {\n"
1367               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1368               + "        \"pdb_id\":\"1sf1\",\n"
1369               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES\"},\n"
1370               + "      {\n"
1371               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1372               + "        \"pdb_id\":\"1sf1\",\n"
1373               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES\"},\n"
1374               + "      {\n"
1375               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1376               + "        \"pdb_id\":\"1t1q\",\n"
1377               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1378               + "      {\n"
1379               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1380               + "        \"pdb_id\":\"1t1q\",\n"
1381               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES\"},\n"
1382               + "      {\n"
1383               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1384               + "        \"pdb_id\":\"3i3z\",\n"
1385               + "        \"resolution\":1.6,\n"
1386               + "        \"title\":\"Human insulin\"},\n"
1387               + "      {\n"
1388               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1389               + "        \"pdb_id\":\"3i3z\",\n"
1390               + "        \"resolution\":1.6,\n"
1391               + "        \"title\":\"Human insulin\"},\n"
1392               + "      {\n"
1393               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1394               + "        \"pdb_id\":\"3i40\",\n"
1395               + "        \"resolution\":1.85,\n"
1396               + "        \"title\":\"Human insulin\"},\n"
1397               + "      {\n"
1398               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1399               + "        \"pdb_id\":\"1iog\",\n"
1400               + "        \"title\":\"INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES\"},\n"
1401               + "      {\n"
1402               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1403               + "        \"pdb_id\":\"1mso\",\n"
1404               + "        \"resolution\":1.0,\n"
1405               + "        \"title\":\"T6 Human Insulin at 1.0 A Resolution\"},\n"
1406               + "      {\n"
1407               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1408               + "        \"pdb_id\":\"1jco\",\n"
1409               + "        \"title\":\"Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin)\"},\n"
1410               + "      {\n"
1411               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1412               + "        \"pdb_id\":\"1a7f\",\n"
1413               + "        \"title\":\"INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES\"},\n"
1414               + "      {\n"
1415               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1416               + "        \"pdb_id\":\"1hls\",\n"
1417               + "        \"title\":\"NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)\"},\n"
1418               + "      {\n"
1419               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1420               + "        \"pdb_id\":\"1hls\",\n"
1421               + "        \"title\":\"NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16)\"},\n"
1422               + "      {\n"
1423               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1424               + "        \"pdb_id\":\"1ioh\",\n"
1425               + "        \"title\":\"INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES\"},\n"
1426               + "      {\n"
1427               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1428               + "        \"pdb_id\":\"4iyd\",\n"
1429               + "        \"resolution\":1.66,\n"
1430               + "        \"title\":\"Insulin glargine crystal structure 1\"},\n"
1431               + "      {\n"
1432               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1433               + "        \"pdb_id\":\"4iyd\",\n"
1434               + "        \"resolution\":1.66,\n"
1435               + "        \"title\":\"Insulin glargine crystal structure 1\"},\n"
1436               + "      {\n"
1437               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1438               + "        \"pdb_id\":\"6s34\",\n"
1439               + "        \"resolution\":1.35,\n"
1440               + "        \"title\":\"Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution\"},\n"
1441               + "      {\n"
1442               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1443               + "        \"pdb_id\":\"6s34\",\n"
1444               + "        \"resolution\":1.35,\n"
1445               + "        \"title\":\"Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution\"},\n"
1446               + "      {\n"
1447               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1448               + "        \"pdb_id\":\"6ves\",\n"
1449               + "        \"resolution\":1.85,\n"
1450               + "        \"title\":\"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI\"},\n"
1451               + "      {\n"
1452               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1453               + "        \"pdb_id\":\"6ves\",\n"
1454               + "        \"resolution\":1.85,\n"
1455               + "        \"title\":\"Human insulin analog: [GluB10,HisA8,ArgA9]-DOI\"},\n"
1456               + "      {\n"
1457               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1458               + "        \"pdb_id\":\"4unh\",\n"
1459               + "        \"resolution\":2.75,\n"
1460               + "        \"title\":\"Human insulin B26Gly mutant crystal structure\"},\n"
1461               + "      {\n"
1462               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1463               + "        \"pdb_id\":\"4unh\",\n"
1464               + "        \"resolution\":2.75,\n"
1465               + "        \"title\":\"Human insulin B26Gly mutant crystal structure\"},\n"
1466               + "      {\n"
1467               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1468               + "        \"pdb_id\":\"2mpg\",\n"
1469               + "        \"title\":\"Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue\"},\n"
1470               + "      {\n"
1471               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1472               + "        \"pdb_id\":\"3w7y\",\n"
1473               + "        \"resolution\":0.92,\n"
1474               + "        \"title\":\"0.92A structure of 2Zn human insulin at 100K\"},\n"
1475               + "      {\n"
1476               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1477               + "        \"pdb_id\":\"3w7y\",\n"
1478               + "        \"resolution\":0.92,\n"
1479               + "        \"title\":\"0.92A structure of 2Zn human insulin at 100K\"},\n"
1480               + "      {\n"
1481               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1482               + "        \"pdb_id\":\"3w7z\",\n"
1483               + "        \"resolution\":1.15,\n"
1484               + "        \"title\":\"1.15A structure of human 2Zn insulin at 293K\"},\n"
1485               + "      {\n"
1486               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1487               + "        \"pdb_id\":\"3w7z\",\n"
1488               + "        \"resolution\":1.15,\n"
1489               + "        \"title\":\"1.15A structure of human 2Zn insulin at 293K\"},\n"
1490               + "      {\n"
1491               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1492               + "        \"pdb_id\":\"4ak0\",\n"
1493               + "        \"resolution\":2.28,\n"
1494               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
1495               + "      {\n"
1496               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1497               + "        \"pdb_id\":\"4ak0\",\n"
1498               + "        \"resolution\":2.28,\n"
1499               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
1500               + "      {\n"
1501               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1502               + "        \"pdb_id\":\"5uoz\",\n"
1503               + "        \"resolution\":1.1746387,\n"
1504               + "        \"title\":\"Insulin with proline analog FyP at position B28 in the T2 state\"},\n"
1505               + "      {\n"
1506               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1507               + "        \"pdb_id\":\"5uoz\",\n"
1508               + "        \"resolution\":1.1746387,\n"
1509               + "        \"title\":\"Insulin with proline analog FyP at position B28 in the T2 state\"},\n"
1510               + "      {\n"
1511               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1512               + "        \"pdb_id\":\"4ung\",\n"
1513               + "        \"resolution\":1.81,\n"
1514               + "        \"title\":\"Human insulin B26Asn mutant crystal structure\"},\n"
1515               + "      {\n"
1516               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1517               + "        \"pdb_id\":\"2r35\",\n"
1518               + "        \"resolution\":2.08,\n"
1519               + "        \"title\":\"Crystal structure of RB human arg-insulin\"},\n"
1520               + "      {\n"
1521               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1522               + "        \"pdb_id\":\"2hiu\",\n"
1523               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES\"},\n"
1524               + "      {\n"
1525               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1526               + "        \"pdb_id\":\"2hiu\",\n"
1527               + "        \"title\":\"NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES\"},\n"
1528               + "      {\n"
1529               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1530               + "        \"pdb_id\":\"2m2m\",\n"
1531               + "        \"title\":\"Structure of [L-HisB24] insulin analogue at pH 1.9\"},\n"
1532               + "      {\n"
1533               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1534               + "        \"pdb_id\":\"2m2m\",\n"
1535               + "        \"title\":\"Structure of [L-HisB24] insulin analogue at pH 1.9\"},\n"
1536               + "      {\n"
1537               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1538               + "        \"pdb_id\":\"2wrx\",\n"
1539               + "        \"resolution\":1.5,\n"
1540               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0\"},\n"
1541               + "      {\n"
1542               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1543               + "        \"pdb_id\":\"2wrx\",\n"
1544               + "        \"resolution\":1.5,\n"
1545               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0\"},\n"
1546               + "      {\n"
1547               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1548               + "        \"pdb_id\":\"2hho\",\n"
1549               + "        \"title\":\"NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1550               + "      {\n"
1551               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1552               + "        \"pdb_id\":\"2hh4\",\n"
1553               + "        \"title\":\"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1554               + "      {\n"
1555               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1556               + "        \"pdb_id\":\"2hh4\",\n"
1557               + "        \"title\":\"NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structures\"},\n"
1558               + "      {\n"
1559               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1560               + "        \"pdb_id\":\"2kxk\",\n"
1561               + "        \"title\":\"Human Insulin Mutant A22Gly-B31Lys-B32Arg\"},\n"
1562               + "      {\n"
1563               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1564               + "        \"pdb_id\":\"2kxk\",\n"
1565               + "        \"title\":\"Human Insulin Mutant A22Gly-B31Lys-B32Arg\"},\n"
1566               + "      {\n"
1567               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1568               + "        \"pdb_id\":\"4cxn\",\n"
1569               + "        \"resolution\":1.7,\n"
1570               + "        \"title\":\"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I\"},\n"
1571               + "      {\n"
1572               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1573               + "        \"pdb_id\":\"4cxn\",\n"
1574               + "        \"resolution\":1.7,\n"
1575               + "        \"title\":\"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I\"},\n"
1576               + "      {\n"
1577               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1578               + "        \"pdb_id\":\"2ws0\",\n"
1579               + "        \"resolution\":2.1,\n"
1580               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5\"},\n"
1581               + "      {\n"
1582               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1583               + "        \"pdb_id\":\"2kqq\",\n"
1584               + "        \"title\":\"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures\"},\n"
1585               + "      {\n"
1586               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1587               + "        \"pdb_id\":\"2l1y\",\n"
1588               + "        \"title\":\"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures\"},\n"
1589               + "      {\n"
1590               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1591               + "        \"pdb_id\":\"1os3\",\n"
1592               + "        \"resolution\":1.95,\n"
1593               + "        \"title\":\"Dehydrated T6 human insulin at 100 K\"},\n"
1594               + "      {\n"
1595               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1596               + "        \"pdb_id\":\"1os3\",\n"
1597               + "        \"resolution\":1.95,\n"
1598               + "        \"title\":\"Dehydrated T6 human insulin at 100 K\"},\n"
1599               + "      {\n"
1600               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1601               + "        \"pdb_id\":\"3aiy\",\n"
1602               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE\"},\n"
1603               + "      {\n"
1604               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1605               + "        \"pdb_id\":\"3aiy\",\n"
1606               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE\"},\n"
1607               + "      {\n"
1608               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1609               + "        \"pdb_id\":\"2aiy\",\n"
1610               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES\"},\n"
1611               + "      {\n"
1612               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1613               + "        \"pdb_id\":\"3inc\",\n"
1614               + "        \"resolution\":1.85,\n"
1615               + "        \"title\":\"Crystal structure of human insulin with Ni+2 complex\"},\n"
1616               + "      {\n"
1617               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1618               + "        \"pdb_id\":\"3inc\",\n"
1619               + "        \"resolution\":1.85,\n"
1620               + "        \"title\":\"Crystal structure of human insulin with Ni+2 complex\"},\n"
1621               + "      {\n"
1622               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1623               + "        \"pdb_id\":\"1mso\",\n"
1624               + "        \"resolution\":1.0,\n"
1625               + "        \"title\":\"T6 Human Insulin at 1.0 A Resolution\"},\n"
1626               + "      {\n"
1627               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1628               + "        \"pdb_id\":\"1mhi\",\n"
1629               + "        \"title\":\"THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS\"},\n"
1630               + "      {\n"
1631               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1632               + "        \"pdb_id\":\"1mhi\",\n"
1633               + "        \"title\":\"THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN INSULIN USING NUCLEAR MAGNETIC RESONANCE DISTANCE GEOMETRY AND RESTRAINED MOLECULAR DYNAMICS\"},\n"
1634               + "      {\n"
1635               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1636               + "        \"pdb_id\":\"1mhj\",\n"
1637               + "        \"title\":\"SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF THE STRUCTURAL BASIS FOR THE MONOMERIZATION OF THE DES-[PHE(B25)] INSULIN AND THE DIMERIZATION OF NATIVE INSULIN\"},\n"
1638               + "      {\n"
1639               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1640               + "        \"pdb_id\":\"1mhj\",\n"
1641               + "        \"title\":\"SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF THE STRUCTURAL BASIS FOR THE MONOMERIZATION OF THE DES-[PHE(B25)] INSULIN AND THE DIMERIZATION OF NATIVE INSULIN\"},\n"
1642               + "      {\n"
1643               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1644               + "        \"pdb_id\":\"1aiy\",\n"
1645               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES\"},\n"
1646               + "      {\n"
1647               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1648               + "        \"pdb_id\":\"2k91\",\n"
1649               + "        \"title\":\"Enhancing the activity of insulin by stereospecific unfolding\"},\n"
1650               + "      {\n"
1651               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1652               + "        \"pdb_id\":\"2k91\",\n"
1653               + "        \"title\":\"Enhancing the activity of insulin by stereospecific unfolding\"},\n"
1654               + "      {\n"
1655               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1656               + "        \"pdb_id\":\"4iyf\",\n"
1657               + "        \"resolution\":1.8,\n"
1658               + "        \"title\":\"Insulin glargine crystal structure 2\"},\n"
1659               + "      {\n"
1660               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1661               + "        \"pdb_id\":\"4iyf\",\n"
1662               + "        \"resolution\":1.8,\n"
1663               + "        \"title\":\"Insulin glargine crystal structure 2\"},\n"
1664               + "      {\n"
1665               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1666               + "        \"pdb_id\":\"5aiy\",\n"
1667               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE\"},\n"
1668               + "      {\n"
1669               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1670               + "        \"pdb_id\":\"5aiy\",\n"
1671               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE\"},\n"
1672               + "      {\n"
1673               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1674               + "        \"pdb_id\":\"4une\",\n"
1675               + "        \"resolution\":1.59,\n"
1676               + "        \"title\":\"Human insulin B26Phe mutant crystal structure\"},\n"
1677               + "      {\n"
1678               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1679               + "        \"pdb_id\":\"4une\",\n"
1680               + "        \"resolution\":1.59,\n"
1681               + "        \"title\":\"Human insulin B26Phe mutant crystal structure\"},\n"
1682               + "      {\n"
1683               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1684               + "        \"pdb_id\":\"5hqi\",\n"
1685               + "        \"resolution\":0.97,\n"
1686               + "        \"title\":\"Insulin with proline analog HzP at position B28 in the T2 state\"},\n"
1687               + "      {\n"
1688               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1689               + "        \"pdb_id\":\"5hqi\",\n"
1690               + "        \"resolution\":0.97,\n"
1691               + "        \"title\":\"Insulin with proline analog HzP at position B28 in the T2 state\"},\n"
1692               + "      {\n"
1693               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1694               + "        \"pdb_id\":\"2mli\",\n"
1695               + "        \"title\":\"NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin\"},\n"
1696               + "      {\n"
1697               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1698               + "        \"pdb_id\":\"2mpg\",\n"
1699               + "        \"title\":\"Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue\"},\n"
1700               + "      {\n"
1701               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1702               + "        \"pdb_id\":\"4aiy\",\n"
1703               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE\"},\n"
1704               + "      {\n"
1705               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1706               + "        \"pdb_id\":\"4aiy\",\n"
1707               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE\"},\n"
1708               + "      {\n"
1709               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1710               + "        \"pdb_id\":\"4ewx\",\n"
1711               + "        \"resolution\":2.201,\n"
1712               + "        \"title\":\"Human Insulin\"},\n"
1713               + "      {\n"
1714               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1715               + "        \"pdb_id\":\"4eww\",\n"
1716               + "        \"resolution\":2.3,\n"
1717               + "        \"title\":\"Human Insulin\"},\n"
1718               + "      {\n"
1719               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1720               + "        \"pdb_id\":\"3w80\",\n"
1721               + "        \"resolution\":1.4,\n"
1722               + "        \"title\":\"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell\"},\n"
1723               + "      {\n"
1724               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1725               + "        \"pdb_id\":\"3w80\",\n"
1726               + "        \"resolution\":1.4,\n"
1727               + "        \"title\":\"Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin cell\"},\n"
1728               + "      {\n"
1729               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1730               + "        \"pdb_id\":\"3tt8\",\n"
1731               + "        \"resolution\":1.12,\n"
1732               + "        \"title\":\"Crystal Structure Analysis of Cu Human Insulin Derivative\"},\n"
1733               + "      {\n"
1734               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1735               + "        \"pdb_id\":\"3tt8\",\n"
1736               + "        \"resolution\":1.12,\n"
1737               + "        \"title\":\"Crystal Structure Analysis of Cu Human Insulin Derivative\"},\n"
1738               + "      {\n"
1739               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1740               + "        \"pdb_id\":\"2n2v\",\n"
1741               + "        \"title\":\"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9\"},\n"
1742               + "      {\n"
1743               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1744               + "        \"pdb_id\":\"2n2w\",\n"
1745               + "        \"title\":\"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0\"},\n"
1746               + "      {\n"
1747               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1748               + "        \"pdb_id\":\"2n2x\",\n"
1749               + "        \"title\":\"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9\"},\n"
1750               + "      {\n"
1751               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1752               + "        \"pdb_id\":\"4ung\",\n"
1753               + "        \"resolution\":1.81,\n"
1754               + "        \"title\":\"Human insulin B26Asn mutant crystal structure\"},\n"
1755               + "      {\n"
1756               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1757               + "        \"pdb_id\":\"2r34\",\n"
1758               + "        \"resolution\":2.25,\n"
1759               + "        \"title\":\"Crystal structure of MN human arg-insulin\"},\n"
1760               + "      {\n"
1761               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1762               + "        \"pdb_id\":\"2mpi\",\n"
1763               + "        \"title\":\"Solution structure of B24G insulin\"},\n"
1764               + "      {\n"
1765               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1766               + "        \"pdb_id\":\"2mpi\",\n"
1767               + "        \"title\":\"Solution structure of B24G insulin\"},\n"
1768               + "      {\n"
1769               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1770               + "        \"pdb_id\":\"5mhd\",\n"
1771               + "        \"title\":\"Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutions.\"},\n"
1772               + "      {\n"
1773               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1774               + "        \"pdb_id\":\"5mhd\",\n"
1775               + "        \"title\":\"Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutions.\"},\n"
1776               + "      {\n"
1777               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1778               + "        \"pdb_id\":\"2ws1\",\n"
1779               + "        \"resolution\":1.6,\n"
1780               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form\"},\n"
1781               + "      {\n"
1782               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1783               + "        \"pdb_id\":\"2ws1\",\n"
1784               + "        \"resolution\":1.6,\n"
1785               + "        \"title\":\"Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form\"},\n"
1786               + "      {\n"
1787               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1788               + "        \"pdb_id\":\"4f1c\",\n"
1789               + "        \"resolution\":1.7,\n"
1790               + "        \"title\":\"Human Insulin\"},\n"
1791               + "      {\n"
1792               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1793               + "        \"pdb_id\":\"4f1d\",\n"
1794               + "        \"resolution\":1.637,\n"
1795               + "        \"title\":\"Human Insulin\"},\n"
1796               + "      {\n"
1797               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1798               + "        \"pdb_id\":\"4f0o\",\n"
1799               + "        \"resolution\":1.672,\n"
1800               + "        \"title\":\"Human Insulin\"},\n"
1801               + "      {\n"
1802               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1803               + "        \"pdb_id\":\"4f1g\",\n"
1804               + "        \"resolution\":1.637,\n"
1805               + "        \"title\":\"Human insulin\"},\n"
1806               + "      {\n"
1807               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1808               + "        \"pdb_id\":\"4f4v\",\n"
1809               + "        \"resolution\":1.637,\n"
1810               + "        \"title\":\"Human Insulin\"},\n"
1811               + "      {\n"
1812               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1813               + "        \"pdb_id\":\"4f51\",\n"
1814               + "        \"resolution\":1.637,\n"
1815               + "        \"title\":\"Human Insulin\"},\n"
1816               + "      {\n"
1817               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1818               + "        \"pdb_id\":\"4f8f\",\n"
1819               + "        \"resolution\":1.676,\n"
1820               + "        \"title\":\"Human Insulin\"},\n"
1821               + "      {\n"
1822               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1823               + "        \"pdb_id\":\"4f1f\",\n"
1824               + "        \"resolution\":1.684,\n"
1825               + "        \"title\":\"Human Insulin\"},\n"
1826               + "      {\n"
1827               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1828               + "        \"pdb_id\":\"2wru\",\n"
1829               + "        \"resolution\":1.57,\n"
1830               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2\"},\n"
1831               + "      {\n"
1832               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1833               + "        \"pdb_id\":\"2wru\",\n"
1834               + "        \"resolution\":1.57,\n"
1835               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2\"},\n"
1836               + "      {\n"
1837               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1838               + "        \"pdb_id\":\"2kqq\",\n"
1839               + "        \"title\":\"NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 structures\"},\n"
1840               + "      {\n"
1841               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1842               + "        \"pdb_id\":\"2l1y\",\n"
1843               + "        \"title\":\"NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Structures\"},\n"
1844               + "      {\n"
1845               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1846               + "        \"pdb_id\":\"4f1a\",\n"
1847               + "        \"resolution\":1.8,\n"
1848               + "        \"title\":\"Human Insulin\"},\n"
1849               + "      {\n"
1850               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1851               + "        \"pdb_id\":\"4f1a\",\n"
1852               + "        \"resolution\":1.8,\n"
1853               + "        \"title\":\"Human Insulin\"},\n"
1854               + "      {\n"
1855               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1856               + "        \"pdb_id\":\"4f0n\",\n"
1857               + "        \"resolution\":1.679,\n"
1858               + "        \"title\":\"Human Insulin\"},\n"
1859               + "      {\n"
1860               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1861               + "        \"pdb_id\":\"4f0n\",\n"
1862               + "        \"resolution\":1.679,\n"
1863               + "        \"title\":\"Human Insulin\"},\n"
1864               + "      {\n"
1865               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1866               + "        \"pdb_id\":\"4f4t\",\n"
1867               + "        \"resolution\":1.637,\n"
1868               + "        \"title\":\"Human Insulin\"},\n"
1869               + "      {\n"
1870               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1871               + "        \"pdb_id\":\"4f1b\",\n"
1872               + "        \"resolution\":1.591,\n"
1873               + "        \"title\":\"Human Insulin\"},\n"
1874               + "      {\n"
1875               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1876               + "        \"pdb_id\":\"1jca\",\n"
1877               + "        \"resolution\":2.5,\n"
1878               + "        \"title\":\"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity\"},\n"
1879               + "      {\n"
1880               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1881               + "        \"pdb_id\":\"3bxq\",\n"
1882               + "        \"resolution\":1.3,\n"
1883               + "        \"title\":\"The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition\"},\n"
1884               + "      {\n"
1885               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1886               + "        \"pdb_id\":\"1htv\",\n"
1887               + "        \"resolution\":1.9,\n"
1888               + "        \"title\":\"CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN\"},\n"
1889               + "      {\n"
1890               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1891               + "        \"pdb_id\":\"1htv\",\n"
1892               + "        \"resolution\":1.9,\n"
1893               + "        \"title\":\"CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN\"},\n"
1894               + "      {\n"
1895               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1896               + "        \"pdb_id\":\"1ai0\",\n"
1897               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES\"},\n"
1898               + "      {\n"
1899               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1900               + "        \"pdb_id\":\"1ai0\",\n"
1901               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES\"},\n"
1902               + "      {\n"
1903               + "        \"experimental_method\":[\"Solution NMR\"],\n"
1904               + "        \"pdb_id\":\"1aiy\",\n"
1905               + "        \"title\":\"R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES\"},\n"
1906               + "      {\n"
1907               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1908               + "        \"pdb_id\":\"5bts\",\n"
1909               + "        \"resolution\":1.77,\n"
1910               + "        \"title\":\"Structural and biophysical characterization of a covalent insulin dimer formed during storage of neutral formulation of human insulin\"},\n"
1911               + "      {\n"
1912               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1913               + "        \"pdb_id\":\"5bts\",\n"
1914               + "        \"resolution\":1.77,\n"
1915               + "        \"title\":\"Structural and biophysical characterization of a covalent insulin dimer formed during storage of neutral formulation of human insulin\"},\n"
1916               + "      {\n"
1917               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1918               + "        \"pdb_id\":\"5usp\",\n"
1919               + "        \"resolution\":1.174,\n"
1920               + "        \"title\":\"Insulin with proline analog Pip at position B28 in the T2 state\"},\n"
1921               + "      {\n"
1922               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1923               + "        \"pdb_id\":\"5usp\",\n"
1924               + "        \"resolution\":1.174,\n"
1925               + "        \"title\":\"Insulin with proline analog Pip at position B28 in the T2 state\"},\n"
1926               + "      {\n"
1927               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1928               + "        \"pdb_id\":\"5bpo\",\n"
1929               + "        \"resolution\":1.9,\n"
1930               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B27 and B29\"},\n"
1931               + "      {\n"
1932               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1933               + "        \"pdb_id\":\"5uu2\",\n"
1934               + "        \"resolution\":1.223,\n"
1935               + "        \"title\":\"Insulin with proline analog ThioP at position B28 in the T2 state\"},\n"
1936               + "      {\n"
1937               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1938               + "        \"pdb_id\":\"5urt\",\n"
1939               + "        \"resolution\":1.18,\n"
1940               + "        \"title\":\"Insulin with proline analog DhP at position B28 in the T2 state\"},\n"
1941               + "      {\n"
1942               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1943               + "        \"pdb_id\":\"6h3m\",\n"
1944               + "        \"resolution\":1.821,\n"
1945               + "        \"title\":\"The crystal structure of a human seleno-insulin analog\"},\n"
1946               + "      {\n"
1947               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1948               + "        \"pdb_id\":\"6h3m\",\n"
1949               + "        \"resolution\":1.821,\n"
1950               + "        \"title\":\"The crystal structure of a human seleno-insulin analog\"},\n"
1951               + "      {\n"
1952               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1953               + "        \"pdb_id\":\"6ver\",\n"
1954               + "        \"resolution\":1.047,\n"
1955               + "        \"title\":\"Human insulin analog: [GluB10,TyrB20]-DOI\"},\n"
1956               + "      {\n"
1957               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1958               + "        \"pdb_id\":\"6ver\",\n"
1959               + "        \"resolution\":1.047,\n"
1960               + "        \"title\":\"Human insulin analog: [GluB10,TyrB20]-DOI\"},\n"
1961               + "      {\n"
1962               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1963               + "        \"pdb_id\":\"4ewx\",\n"
1964               + "        \"resolution\":2.201,\n"
1965               + "        \"title\":\"Human Insulin\"},\n"
1966               + "      {\n"
1967               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1968               + "        \"pdb_id\":\"4ey1\",\n"
1969               + "        \"resolution\":1.471,\n"
1970               + "        \"title\":\"Human Insulin\"},\n"
1971               + "      {\n"
1972               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1973               + "        \"pdb_id\":\"4eww\",\n"
1974               + "        \"resolution\":2.3,\n"
1975               + "        \"title\":\"Human Insulin\"},\n"
1976               + "      {\n"
1977               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1978               + "        \"pdb_id\":\"4exx\",\n"
1979               + "        \"resolution\":1.55,\n"
1980               + "        \"title\":\"Human Insulin\"},\n"
1981               + "      {\n"
1982               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1983               + "        \"pdb_id\":\"4exx\",\n"
1984               + "        \"resolution\":1.55,\n"
1985               + "        \"title\":\"Human Insulin\"},\n"
1986               + "      {\n"
1987               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1988               + "        \"pdb_id\":\"4eyp\",\n"
1989               + "        \"resolution\":1.591,\n"
1990               + "        \"title\":\"Human Insulin\"},\n"
1991               + "      {\n"
1992               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1993               + "        \"pdb_id\":\"4ewz\",\n"
1994               + "        \"resolution\":1.791,\n"
1995               + "        \"title\":\"Human Insulin\"},\n"
1996               + "      {\n"
1997               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
1998               + "        \"pdb_id\":\"4ewz\",\n"
1999               + "        \"resolution\":1.791,\n"
2000               + "        \"title\":\"Human Insulin\"},\n"
2001               + "      {\n"
2002               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2003               + "        \"pdb_id\":\"4ex0\",\n"
2004               + "        \"resolution\":1.86,\n"
2005               + "        \"title\":\"Human Insulin\"},\n"
2006               + "      {\n"
2007               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2008               + "        \"pdb_id\":\"4ex0\",\n"
2009               + "        \"resolution\":1.86,\n"
2010               + "        \"title\":\"Human Insulin\"},\n"
2011               + "      {\n"
2012               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2013               + "        \"pdb_id\":\"4eyd\",\n"
2014               + "        \"resolution\":1.471,\n"
2015               + "        \"title\":\"Human Insulin\"},\n"
2016               + "      {\n"
2017               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2018               + "        \"pdb_id\":\"4eyd\",\n"
2019               + "        \"resolution\":1.471,\n"
2020               + "        \"title\":\"Human Insulin\"},\n"
2021               + "      {\n"
2022               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2023               + "        \"pdb_id\":\"4ex1\",\n"
2024               + "        \"resolution\":1.657,\n"
2025               + "        \"title\":\"Human Insulin\"},\n"
2026               + "      {\n"
2027               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2028               + "        \"pdb_id\":\"3q6e\",\n"
2029               + "        \"resolution\":2.05,\n"
2030               + "        \"title\":\"Human insulin in complex with cucurbit[7]uril\"},\n"
2031               + "      {\n"
2032               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2033               + "        \"pdb_id\":\"3q6e\",\n"
2034               + "        \"resolution\":2.05,\n"
2035               + "        \"title\":\"Human insulin in complex with cucurbit[7]uril\"},\n"
2036               + "      {\n"
2037               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2038               + "        \"pdb_id\":\"2n2v\",\n"
2039               + "        \"title\":\"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9\"},\n"
2040               + "      {\n"
2041               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2042               + "        \"pdb_id\":\"2n2w\",\n"
2043               + "        \"title\":\"Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0\"},\n"
2044               + "      {\n"
2045               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2046               + "        \"pdb_id\":\"2n2x\",\n"
2047               + "        \"title\":\"Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9\"},\n"
2048               + "      {\n"
2049               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2050               + "        \"pdb_id\":\"4ey9\",\n"
2051               + "        \"resolution\":1.471,\n"
2052               + "        \"title\":\"Human Insulin\"},\n"
2053               + "      {\n"
2054               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2055               + "        \"pdb_id\":\"4ey9\",\n"
2056               + "        \"resolution\":1.471,\n"
2057               + "        \"title\":\"Human Insulin\"},\n"
2058               + "      {\n"
2059               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2060               + "        \"pdb_id\":\"4fka\",\n"
2061               + "        \"resolution\":1.08,\n"
2062               + "        \"title\":\"High resolution structure of the manganese derivative of insulin\"},\n"
2063               + "      {\n"
2064               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2065               + "        \"pdb_id\":\"4eyn\",\n"
2066               + "        \"resolution\":1.532,\n"
2067               + "        \"title\":\"Human Insulin\"},\n"
2068               + "      {\n"
2069               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2070               + "        \"pdb_id\":\"4eyn\",\n"
2071               + "        \"resolution\":1.532,\n"
2072               + "        \"title\":\"Human Insulin\"},\n"
2073               + "      {\n"
2074               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2075               + "        \"pdb_id\":\"4rxw\",\n"
2076               + "        \"resolution\":1.73,\n"
2077               + "        \"title\":\"Crystal Structure of the cobalt human insulin derivative\"},\n"
2078               + "      {\n"
2079               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2080               + "        \"pdb_id\":\"4rxw\",\n"
2081               + "        \"resolution\":1.73,\n"
2082               + "        \"title\":\"Crystal Structure of the cobalt human insulin derivative\"},\n"
2083               + "      {\n"
2084               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2085               + "        \"pdb_id\":\"5usv\",\n"
2086               + "        \"resolution\":1.3,\n"
2087               + "        \"title\":\"Insulin with proline analog AzeP at position B28 in the T2 state\"},\n"
2088               + "      {\n"
2089               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2090               + "        \"pdb_id\":\"5usv\",\n"
2091               + "        \"resolution\":1.3,\n"
2092               + "        \"title\":\"Insulin with proline analog AzeP at position B28 in the T2 state\"},\n"
2093               + "      {\n"
2094               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2095               + "        \"pdb_id\":\"2wrv\",\n"
2096               + "        \"resolution\":2.15,\n"
2097               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2\"},\n"
2098               + "      {\n"
2099               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2100               + "        \"pdb_id\":\"2wrv\",\n"
2101               + "        \"resolution\":2.15,\n"
2102               + "        \"title\":\"Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2\"},\n"
2103               + "      {\n"
2104               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2105               + "        \"pdb_id\":\"2vk0\",\n"
2106               + "        \"resolution\":2.2,\n"
2107               + "        \"title\":\"Crystal structure form ultalente insulin microcrystals\"},\n"
2108               + "      {\n"
2109               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2110               + "        \"pdb_id\":\"3exx\",\n"
2111               + "        \"resolution\":1.35,\n"
2112               + "        \"title\":\"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution\"},\n"
2113               + "      {\n"
2114               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2115               + "        \"pdb_id\":\"3exx\",\n"
2116               + "        \"resolution\":1.35,\n"
2117               + "        \"title\":\"Structure of the T6 human insulin derivative with nickel at 1.35 A resolution\"},\n"
2118               + "      {\n"
2119               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2120               + "        \"pdb_id\":\"2vjz\",\n"
2121               + "        \"resolution\":1.8,\n"
2122               + "        \"title\":\"Crystal structure form ultalente insulin microcrystals\"},\n"
2123               + "      {\n"
2124               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2125               + "        \"pdb_id\":\"4f1c\",\n"
2126               + "        \"resolution\":1.7,\n"
2127               + "        \"title\":\"Human Insulin\"},\n"
2128               + "      {\n"
2129               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2130               + "        \"pdb_id\":\"4f1d\",\n"
2131               + "        \"resolution\":1.637,\n"
2132               + "        \"title\":\"Human Insulin\"},\n"
2133               + "      {\n"
2134               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2135               + "        \"pdb_id\":\"4f0o\",\n"
2136               + "        \"resolution\":1.672,\n"
2137               + "        \"title\":\"Human Insulin\"},\n"
2138               + "      {\n"
2139               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2140               + "        \"pdb_id\":\"4gbc\",\n"
2141               + "        \"resolution\":1.778,\n"
2142               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2143               + "      {\n"
2144               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2145               + "        \"pdb_id\":\"4gbn\",\n"
2146               + "        \"resolution\":1.872,\n"
2147               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2148               + "      {\n"
2149               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2150               + "        \"pdb_id\":\"4f1g\",\n"
2151               + "        \"resolution\":1.637,\n"
2152               + "        \"title\":\"Human insulin\"},\n"
2153               + "      {\n"
2154               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2155               + "        \"pdb_id\":\"4f4v\",\n"
2156               + "        \"resolution\":1.637,\n"
2157               + "        \"title\":\"Human Insulin\"},\n"
2158               + "      {\n"
2159               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2160               + "        \"pdb_id\":\"4f51\",\n"
2161               + "        \"resolution\":1.637,\n"
2162               + "        \"title\":\"Human Insulin\"},\n"
2163               + "      {\n"
2164               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2165               + "        \"pdb_id\":\"4f1f\",\n"
2166               + "        \"resolution\":1.684,\n"
2167               + "        \"title\":\"Human Insulin\"},\n"
2168               + "      {\n"
2169               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2170               + "        \"pdb_id\":\"4f8f\",\n"
2171               + "        \"resolution\":1.676,\n"
2172               + "        \"title\":\"Human Insulin\"},\n"
2173               + "      {\n"
2174               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2175               + "        \"pdb_id\":\"4gbi\",\n"
2176               + "        \"resolution\":2.502,\n"
2177               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2178               + "      {\n"
2179               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2180               + "        \"pdb_id\":\"4cxl\",\n"
2181               + "        \"resolution\":1.5,\n"
2182               + "        \"title\":\"Human insulin analogue (D-ProB8)-insulin\"},\n"
2183               + "      {\n"
2184               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2185               + "        \"pdb_id\":\"4cxl\",\n"
2186               + "        \"resolution\":1.5,\n"
2187               + "        \"title\":\"Human insulin analogue (D-ProB8)-insulin\"},\n"
2188               + "      {\n"
2189               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2190               + "        \"pdb_id\":\"2r36\",\n"
2191               + "        \"resolution\":2.0,\n"
2192               + "        \"title\":\"Crystal structure of ni human ARG-insulin\"},\n"
2193               + "      {\n"
2194               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2195               + "        \"pdb_id\":\"4f4t\",\n"
2196               + "        \"resolution\":1.637,\n"
2197               + "        \"title\":\"Human Insulin\"},\n"
2198               + "      {\n"
2199               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2200               + "        \"pdb_id\":\"4f1b\",\n"
2201               + "        \"resolution\":1.591,\n"
2202               + "        \"title\":\"Human Insulin\"},\n"
2203               + "      {\n"
2204               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2205               + "        \"pdb_id\":\"3ir0\",\n"
2206               + "        \"resolution\":2.2,\n"
2207               + "        \"title\":\"Crystal Structure of Human Insulin complexed with Cu+2 metal ion\"},\n"
2208               + "      {\n"
2209               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2210               + "        \"pdb_id\":\"3ir0\",\n"
2211               + "        \"resolution\":2.2,\n"
2212               + "        \"title\":\"Crystal Structure of Human Insulin complexed with Cu+2 metal ion\"},\n"
2213               + "      {\n"
2214               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2215               + "        \"pdb_id\":\"1jca\",\n"
2216               + "        \"resolution\":2.5,\n"
2217               + "        \"title\":\"Non-standard Design of Unstable Insulin Analogues with Enhanced Activity\"},\n"
2218               + "      {\n"
2219               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2220               + "        \"pdb_id\":\"3bxq\",\n"
2221               + "        \"resolution\":1.3,\n"
2222               + "        \"title\":\"The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostatic block to the TR transition\"},\n"
2223               + "      {\n"
2224               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2225               + "        \"pdb_id\":\"1b9e\",\n"
2226               + "        \"resolution\":2.5,\n"
2227               + "        \"title\":\"HUMAN INSULIN MUTANT SERB9GLU\"},\n"
2228               + "      {\n"
2229               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2230               + "        \"pdb_id\":\"1b9e\",\n"
2231               + "        \"resolution\":2.5,\n"
2232               + "        \"title\":\"HUMAN INSULIN MUTANT SERB9GLU\"},\n"
2233               + "      {\n"
2234               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2235               + "        \"pdb_id\":\"2ceu\",\n"
2236               + "        \"resolution\":1.8,\n"
2237               + "        \"title\":\"Despentapeptide insulin in acetic acid (pH 2)\"},\n"
2238               + "      {\n"
2239               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2240               + "        \"pdb_id\":\"2ceu\",\n"
2241               + "        \"resolution\":1.8,\n"
2242               + "        \"title\":\"Despentapeptide insulin in acetic acid (pH 2)\"},\n"
2243               + "      {\n"
2244               + "        \"experimental_method\":[\"X-ray powder diffraction\"],\n"
2245               + "        \"pdb_id\":\"1fub\",\n"
2246               + "        \"title\":\"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA\"},\n"
2247               + "      {\n"
2248               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2249               + "        \"pdb_id\":\"5bpo\",\n"
2250               + "        \"resolution\":1.9,\n"
2251               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B27 and B29\"},\n"
2252               + "      {\n"
2253               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2254               + "        \"pdb_id\":\"5uu2\",\n"
2255               + "        \"resolution\":1.223,\n"
2256               + "        \"title\":\"Insulin with proline analog ThioP at position B28 in the T2 state\"},\n"
2257               + "      {\n"
2258               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2259               + "        \"pdb_id\":\"2mli\",\n"
2260               + "        \"title\":\"NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin\"},\n"
2261               + "      {\n"
2262               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2263               + "        \"pdb_id\":\"4ey1\",\n"
2264               + "        \"resolution\":1.471,\n"
2265               + "        \"title\":\"Human Insulin\"},\n"
2266               + "      {\n"
2267               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2268               + "        \"pdb_id\":\"4eyp\",\n"
2269               + "        \"resolution\":1.591,\n"
2270               + "        \"title\":\"Human Insulin\"},\n"
2271               + "      {\n"
2272               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2273               + "        \"pdb_id\":\"4ex1\",\n"
2274               + "        \"resolution\":1.657,\n"
2275               + "        \"title\":\"Human Insulin\"},\n"
2276               + "      {\n"
2277               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2278               + "        \"pdb_id\":\"4iuz\",\n"
2279               + "        \"resolution\":1.6,\n"
2280               + "        \"title\":\"High resolution crystal structure of racemic ester insulin\"},\n"
2281               + "      {\n"
2282               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2283               + "        \"pdb_id\":\"5urt\",\n"
2284               + "        \"resolution\":1.18,\n"
2285               + "        \"title\":\"Insulin with proline analog DhP at position B28 in the T2 state\"},\n"
2286               + "      {\n"
2287               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2288               + "        \"pdb_id\":\"4fka\",\n"
2289               + "        \"resolution\":1.08,\n"
2290               + "        \"title\":\"High resolution structure of the manganese derivative of insulin\"},\n"
2291               + "      {\n"
2292               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2293               + "        \"pdb_id\":\"5cny\",\n"
2294               + "        \"resolution\":1.7,\n"
2295               + "        \"title\":\"Crystal Structure of human zinc insulin at pH 5.5\"},\n"
2296               + "      {\n"
2297               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2298               + "        \"pdb_id\":\"2vk0\",\n"
2299               + "        \"resolution\":2.2,\n"
2300               + "        \"title\":\"Crystal structure form ultalente insulin microcrystals\"},\n"
2301               + "      {\n"
2302               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2303               + "        \"pdb_id\":\"2k9r\",\n"
2304               + "        \"title\":\"Enhancing the activity of insulin by stereospecific unfolding\"},\n"
2305               + "      {\n"
2306               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2307               + "        \"pdb_id\":\"2k9r\",\n"
2308               + "        \"title\":\"Enhancing the activity of insulin by stereospecific unfolding\"},\n"
2309               + "      {\n"
2310               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2311               + "        \"pdb_id\":\"2omi\",\n"
2312               + "        \"resolution\":2.24,\n"
2313               + "        \"title\":\"Structure of human insulin cocrystallized with protamine\"},\n"
2314               + "      {\n"
2315               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2316               + "        \"pdb_id\":\"2vjz\",\n"
2317               + "        \"resolution\":1.8,\n"
2318               + "        \"title\":\"Crystal structure form ultalente insulin microcrystals\"},\n"
2319               + "      {\n"
2320               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2321               + "        \"pdb_id\":\"4gbn\",\n"
2322               + "        \"resolution\":1.872,\n"
2323               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2324               + "      {\n"
2325               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2326               + "        \"pdb_id\":\"4gbl\",\n"
2327               + "        \"resolution\":2.5,\n"
2328               + "        \"title\":\"Crystal structure of aspart insulin at pH 8.5\"},\n"
2329               + "      {\n"
2330               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2331               + "        \"pdb_id\":\"4gbl\",\n"
2332               + "        \"resolution\":2.5,\n"
2333               + "        \"title\":\"Crystal structure of aspart insulin at pH 8.5\"},\n"
2334               + "      {\n"
2335               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2336               + "        \"pdb_id\":\"4gbi\",\n"
2337               + "        \"resolution\":2.502,\n"
2338               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2339               + "      {\n"
2340               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2341               + "        \"pdb_id\":\"4cy7\",\n"
2342               + "        \"resolution\":1.4,\n"
2343               + "        \"title\":\"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II\"},\n"
2344               + "      {\n"
2345               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2346               + "        \"pdb_id\":\"2r36\",\n"
2347               + "        \"resolution\":2.0,\n"
2348               + "        \"title\":\"Crystal structure of ni human ARG-insulin\"},\n"
2349               + "      {\n"
2350               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2351               + "        \"pdb_id\":\"4gbc\",\n"
2352               + "        \"resolution\":1.778,\n"
2353               + "        \"title\":\"Crystal structure of aspart insulin at pH 6.5\"},\n"
2354               + "      {\n"
2355               + "        \"experimental_method\":[\"X-ray powder diffraction\"],\n"
2356               + "        \"pdb_id\":\"1fu2\",\n"
2357               + "        \"title\":\"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA\"},\n"
2358               + "      {\n"
2359               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2360               + "        \"pdb_id\":\"1ev3\",\n"
2361               + "        \"resolution\":1.78,\n"
2362               + "        \"title\":\"Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer\"},\n"
2363               + "      {\n"
2364               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2365               + "        \"pdb_id\":\"1j73\",\n"
2366               + "        \"resolution\":2.0,\n"
2367               + "        \"title\":\"Crystal structure of an unstable insulin analog with native activity.\"},\n"
2368               + "      {\n"
2369               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2370               + "        \"pdb_id\":\"1j73\",\n"
2371               + "        \"resolution\":2.0,\n"
2372               + "        \"title\":\"Crystal structure of an unstable insulin analog with native activity.\"},\n"
2373               + "      {\n"
2374               + "        \"experimental_method\":[\"X-ray powder diffraction\"],\n"
2375               + "        \"pdb_id\":\"1fub\",\n"
2376               + "        \"title\":\"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA\"},\n"
2377               + "      {\n"
2378               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2379               + "        \"pdb_id\":\"5co2\",\n"
2380               + "        \"resolution\":1.7,\n"
2381               + "        \"title\":\"Crystalization of human zinc insulin at pH 5.5\"},\n"
2382               + "      {\n"
2383               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2384               + "        \"pdb_id\":\"5co2\",\n"
2385               + "        \"resolution\":1.7,\n"
2386               + "        \"title\":\"Crystalization of human zinc insulin at pH 5.5\"},\n"
2387               + "      {\n"
2388               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2389               + "        \"pdb_id\":\"5boq\",\n"
2390               + "        \"resolution\":1.7,\n"
2391               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B24 and B29\"},\n"
2392               + "      {\n"
2393               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2394               + "        \"pdb_id\":\"5boq\",\n"
2395               + "        \"resolution\":1.7,\n"
2396               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B24 and B29\"},\n"
2397               + "      {\n"
2398               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2399               + "        \"pdb_id\":\"6s4i\",\n"
2400               + "        \"resolution\":1.511,\n"
2401               + "        \"title\":\"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin\"},\n"
2402               + "      {\n"
2403               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2404               + "        \"pdb_id\":\"6s4i\",\n"
2405               + "        \"resolution\":1.511,\n"
2406               + "        \"title\":\"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB30 human insulin\"},\n"
2407               + "      {\n"
2408               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2409               + "        \"pdb_id\":\"6p4z\",\n"
2410               + "        \"resolution\":1.8,\n"
2411               + "        \"title\":\"Structure of gadolinium-caged cobalt (III) insulin hexamer\"},\n"
2412               + "      {\n"
2413               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2414               + "        \"pdb_id\":\"6gv0\",\n"
2415               + "        \"resolution\":1.26,\n"
2416               + "        \"title\":\"Insulin glulisine\"},\n"
2417               + "      {\n"
2418               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2419               + "        \"pdb_id\":\"6vet\",\n"
2420               + "        \"resolution\":1.46,\n"
2421               + "        \"title\":\"Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI\"},\n"
2422               + "      {\n"
2423               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2424               + "        \"pdb_id\":\"6vet\",\n"
2425               + "        \"resolution\":1.46,\n"
2426               + "        \"title\":\"Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI\"},\n"
2427               + "      {\n"
2428               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2429               + "        \"pdb_id\":\"4iuz\",\n"
2430               + "        \"resolution\":1.6,\n"
2431               + "        \"title\":\"High resolution crystal structure of racemic ester insulin\"},\n"
2432               + "      {\n"
2433               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2434               + "        \"pdb_id\":\"4gbk\",\n"
2435               + "        \"resolution\":2.4,\n"
2436               + "        \"title\":\"Crystal structure of aspart insulin at pH 8.5\"},\n"
2437               + "      {\n"
2438               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2439               + "        \"pdb_id\":\"4gbk\",\n"
2440               + "        \"resolution\":2.4,\n"
2441               + "        \"title\":\"Crystal structure of aspart insulin at pH 8.5\"},\n"
2442               + "      {\n"
2443               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2444               + "        \"pdb_id\":\"4efx\",\n"
2445               + "        \"resolution\":1.98,\n"
2446               + "        \"title\":\"Highly biologically active insulin with additional disulfide bond\"},\n"
2447               + "      {\n"
2448               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2449               + "        \"pdb_id\":\"4efx\",\n"
2450               + "        \"resolution\":1.98,\n"
2451               + "        \"title\":\"Highly biologically active insulin with additional disulfide bond\"},\n"
2452               + "      {\n"
2453               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2454               + "        \"pdb_id\":\"5co9\",\n"
2455               + "        \"resolution\":1.92,\n"
2456               + "        \"title\":\"Crystal structure of human zinc insulin at pH 6.5\"},\n"
2457               + "      {\n"
2458               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2459               + "        \"pdb_id\":\"5cny\",\n"
2460               + "        \"resolution\":1.7,\n"
2461               + "        \"title\":\"Crystal Structure of human zinc insulin at pH 5.5\"},\n"
2462               + "      {\n"
2463               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2464               + "        \"pdb_id\":\"2jmn\",\n"
2465               + "        \"title\":\"NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures\"},\n"
2466               + "      {\n"
2467               + "        \"experimental_method\":[\"Solution NMR\"],\n"
2468               + "        \"pdb_id\":\"2jmn\",\n"
2469               + "        \"title\":\"NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures\"},\n"
2470               + "      {\n"
2471               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2472               + "        \"pdb_id\":\"3e7z\",\n"
2473               + "        \"resolution\":1.7,\n"
2474               + "        \"title\":\"Structure of human insulin\"},\n"
2475               + "      {\n"
2476               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2477               + "        \"pdb_id\":\"3e7z\",\n"
2478               + "        \"resolution\":1.7,\n"
2479               + "        \"title\":\"Structure of human insulin\"},\n"
2480               + "      {\n"
2481               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2482               + "        \"pdb_id\":\"2w44\",\n"
2483               + "        \"resolution\":2.0,\n"
2484               + "        \"title\":\"Structure DeltaA1-A4 insulin\"},\n"
2485               + "      {\n"
2486               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2487               + "        \"pdb_id\":\"3e7y\",\n"
2488               + "        \"resolution\":1.6,\n"
2489               + "        \"title\":\"Structure of human insulin\"},\n"
2490               + "      {\n"
2491               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2492               + "        \"pdb_id\":\"3e7y\",\n"
2493               + "        \"resolution\":1.6,\n"
2494               + "        \"title\":\"Structure of human insulin\"},\n"
2495               + "      {\n"
2496               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2497               + "        \"pdb_id\":\"2omi\",\n"
2498               + "        \"resolution\":2.24,\n"
2499               + "        \"title\":\"Structure of human insulin cocrystallized with protamine\"},\n"
2500               + "      {\n"
2501               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2502               + "        \"pdb_id\":\"2ws7\",\n"
2503               + "        \"resolution\":2.59,\n"
2504               + "        \"title\":\"Semi-synthetic analogue of human insulin ProB26-DTI\"},\n"
2505               + "      {\n"
2506               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2507               + "        \"pdb_id\":\"4cy7\",\n"
2508               + "        \"resolution\":1.4,\n"
2509               + "        \"title\":\"Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II\"},\n"
2510               + "      {\n"
2511               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2512               + "        \"pdb_id\":\"4nib\",\n"
2513               + "        \"resolution\":1.4,\n"
2514               + "        \"title\":\"Crystal structure of human insulin mutant B20 D-ala, B23 D-ala\"},\n"
2515               + "      {\n"
2516               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2517               + "        \"pdb_id\":\"4nib\",\n"
2518               + "        \"resolution\":1.4,\n"
2519               + "        \"title\":\"Crystal structure of human insulin mutant B20 D-ala, B23 D-ala\"},\n"
2520               + "      {\n"
2521               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2522               + "        \"pdb_id\":\"1qj0\",\n"
2523               + "        \"resolution\":2.4,\n"
2524               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR\"},\n"
2525               + "      {\n"
2526               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2527               + "        \"pdb_id\":\"1uz9\",\n"
2528               + "        \"resolution\":1.6,\n"
2529               + "        \"title\":\"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins.\"},\n"
2530               + "      {\n"
2531               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2532               + "        \"pdb_id\":\"1uz9\",\n"
2533               + "        \"resolution\":1.6,\n"
2534               + "        \"title\":\"Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins.\"},\n"
2535               + "      {\n"
2536               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2537               + "        \"pdb_id\":\"1trz\",\n"
2538               + "        \"resolution\":1.6,\n"
2539               + "        \"title\":\"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER\"},\n"
2540               + "      {\n"
2541               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2542               + "        \"pdb_id\":\"1trz\",\n"
2543               + "        \"resolution\":1.6,\n"
2544               + "        \"title\":\"CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER\"},\n"
2545               + "      {\n"
2546               + "        \"experimental_method\":[\"X-ray powder diffraction\"],\n"
2547               + "        \"pdb_id\":\"1fu2\",\n"
2548               + "        \"title\":\"FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA\"},\n"
2549               + "      {\n"
2550               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2551               + "        \"pdb_id\":\"1evr\",\n"
2552               + "        \"resolution\":1.9,\n"
2553               + "        \"title\":\"The structure of the resorcinol/insulin R6 hexamer\"},\n"
2554               + "      {\n"
2555               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2556               + "        \"pdb_id\":\"1ev3\",\n"
2557               + "        \"resolution\":1.78,\n"
2558               + "        \"title\":\"Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer\"},\n"
2559               + "      {\n"
2560               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2561               + "        \"pdb_id\":\"1guj\",\n"
2562               + "        \"resolution\":1.62,\n"
2563               + "        \"title\":\"Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation.\"},\n"
2564               + "      {\n"
2565               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2566               + "        \"pdb_id\":\"1guj\",\n"
2567               + "        \"resolution\":1.62,\n"
2568               + "        \"title\":\"Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation.\"},\n"
2569               + "      {\n"
2570               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2571               + "        \"pdb_id\":\"1ev6\",\n"
2572               + "        \"resolution\":1.9,\n"
2573               + "        \"title\":\"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer\"},\n"
2574               + "      {\n"
2575               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2576               + "        \"pdb_id\":\"1ev6\",\n"
2577               + "        \"resolution\":1.9,\n"
2578               + "        \"title\":\"Structure of the monoclinic form of the M-cresol/insulin R6 hexamer\"},\n"
2579               + "      {\n"
2580               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2581               + "        \"pdb_id\":\"6s4j\",\n"
2582               + "        \"resolution\":1.5,\n"
2583               + "        \"title\":\"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin\"},\n"
2584               + "      {\n"
2585               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2586               + "        \"pdb_id\":\"6s4j\",\n"
2587               + "        \"resolution\":1.5,\n"
2588               + "        \"title\":\"Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)amino]ethoxy)ethoxy]acetylamino)ethoxy]ethoxy)acetyl]), desB27, desB30 human insulin\"},\n"
2589               + "      {\n"
2590               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2591               + "        \"pdb_id\":\"5co6\",\n"
2592               + "        \"resolution\":1.8,\n"
2593               + "        \"title\":\"Crystal structure of human zinc insulin at pH 6.5\"},\n"
2594               + "      {\n"
2595               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2596               + "        \"pdb_id\":\"5co6\",\n"
2597               + "        \"resolution\":1.8,\n"
2598               + "        \"title\":\"Crystal structure of human zinc insulin at pH 6.5\"},\n"
2599               + "      {\n"
2600               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2601               + "        \"pdb_id\":\"6p4z\",\n"
2602               + "        \"resolution\":1.8,\n"
2603               + "        \"title\":\"Structure of gadolinium-caged cobalt (III) insulin hexamer\"},\n"
2604               + "      {\n"
2605               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2606               + "        \"pdb_id\":\"6gv0\",\n"
2607               + "        \"resolution\":1.26,\n"
2608               + "        \"title\":\"Insulin glulisine\"},\n"
2609               + "      {\n"
2610               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2611               + "        \"pdb_id\":\"6gnq\",\n"
2612               + "        \"resolution\":2.2,\n"
2613               + "        \"title\":\"Monoclinic crystalline form of human insulin, complexed with meta-cresol\"},\n"
2614               + "      {\n"
2615               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2616               + "        \"pdb_id\":\"5ems\",\n"
2617               + "        \"resolution\":2.3,\n"
2618               + "        \"title\":\"Crystal Structure of an iodinated insulin analog\"},\n"
2619               + "      {\n"
2620               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2621               + "        \"pdb_id\":\"3zu1\",\n"
2622               + "        \"resolution\":1.6,\n"
2623               + "        \"title\":\"Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin\"},\n"
2624               + "      {\n"
2625               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2626               + "        \"pdb_id\":\"3zu1\",\n"
2627               + "        \"resolution\":1.6,\n"
2628               + "        \"title\":\"Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin\"},\n"
2629               + "      {\n"
2630               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2631               + "        \"pdb_id\":\"5co9\",\n"
2632               + "        \"resolution\":1.92,\n"
2633               + "        \"title\":\"Crystal structure of human zinc insulin at pH 6.5\"},\n"
2634               + "      {\n"
2635               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2636               + "        \"pdb_id\":\"2wby\",\n"
2637               + "        \"resolution\":2.6,\n"
2638               + "        \"title\":\"Crystal structure of human insulin-degrading enzyme in complex with insulin\"},\n"
2639               + "      {\n"
2640               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2641               + "        \"pdb_id\":\"2wby\",\n"
2642               + "        \"resolution\":2.6,\n"
2643               + "        \"title\":\"Crystal structure of human insulin-degrading enzyme in complex with insulin\"},\n"
2644               + "      {\n"
2645               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
2646               + "        \"pdb_id\":\"6hn5\",\n"
2647               + "        \"resolution\":3.2,\n"
2648               + "        \"title\":\"Leucine-zippered human insulin receptor ectodomain with single bound insulin - \\\"upper\\\" membrane-distal part\"},\n"
2649               + "      {\n"
2650               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2651               + "        \"pdb_id\":\"2olz\",\n"
2652               + "        \"resolution\":1.7,\n"
2653               + "        \"title\":\"Structure of human insulin in presence of thiocyanate at pH 7.0\"},\n"
2654               + "      {\n"
2655               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2656               + "        \"pdb_id\":\"2olz\",\n"
2657               + "        \"resolution\":1.7,\n"
2658               + "        \"title\":\"Structure of human insulin in presence of thiocyanate at pH 7.0\"},\n"
2659               + "      {\n"
2660               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2661               + "        \"pdb_id\":\"2omg\",\n"
2662               + "        \"resolution\":1.52,\n"
2663               + "        \"title\":\"Structure of human insulin cocrystallized with protamine and urea\"},\n"
2664               + "      {\n"
2665               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2666               + "        \"pdb_id\":\"2w44\",\n"
2667               + "        \"resolution\":2.0,\n"
2668               + "        \"title\":\"Structure DeltaA1-A4 insulin\"},\n"
2669               + "      {\n"
2670               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2671               + "        \"pdb_id\":\"2ws7\",\n"
2672               + "        \"resolution\":2.59,\n"
2673               + "        \"title\":\"Semi-synthetic analogue of human insulin ProB26-DTI\"},\n"
2674               + "      {\n"
2675               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2676               + "        \"pdb_id\":\"4fg3\",\n"
2677               + "        \"resolution\":2.001,\n"
2678               + "        \"title\":\"Crystal Structure Analysis of the Human Insulin\"},\n"
2679               + "      {\n"
2680               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2681               + "        \"pdb_id\":\"4fg3\",\n"
2682               + "        \"resolution\":2.001,\n"
2683               + "        \"title\":\"Crystal Structure Analysis of the Human Insulin\"},\n"
2684               + "      {\n"
2685               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2686               + "        \"pdb_id\":\"1w8p\",\n"
2687               + "        \"resolution\":2.08,\n"
2688               + "        \"title\":\"Structural properties of the B25Tyr-NMe-B26Phe insulin mutant.\"},\n"
2689               + "      {\n"
2690               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2691               + "        \"pdb_id\":\"1w8p\",\n"
2692               + "        \"resolution\":2.08,\n"
2693               + "        \"title\":\"Structural properties of the B25Tyr-NMe-B26Phe insulin mutant.\"},\n"
2694               + "      {\n"
2695               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2696               + "        \"pdb_id\":\"3p33\",\n"
2697               + "        \"resolution\":2.3,\n"
2698               + "        \"title\":\"Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity\"},\n"
2699               + "      {\n"
2700               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2701               + "        \"pdb_id\":\"1znj\",\n"
2702               + "        \"resolution\":2.0,\n"
2703               + "        \"title\":\"INSULIN, MONOCLINIC CRYSTAL FORM\"},\n"
2704               + "      {\n"
2705               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2706               + "        \"pdb_id\":\"1znj\",\n"
2707               + "        \"resolution\":2.0,\n"
2708               + "        \"title\":\"INSULIN, MONOCLINIC CRYSTAL FORM\"},\n"
2709               + "      {\n"
2710               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2711               + "        \"pdb_id\":\"1xw7\",\n"
2712               + "        \"resolution\":2.3,\n"
2713               + "        \"title\":\"Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama\"},\n"
2714               + "      {\n"
2715               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2716               + "        \"pdb_id\":\"1xw7\",\n"
2717               + "        \"resolution\":2.3,\n"
2718               + "        \"title\":\"Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama\"},\n"
2719               + "      {\n"
2720               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2721               + "        \"pdb_id\":\"1qj0\",\n"
2722               + "        \"resolution\":2.4,\n"
2723               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR\"},\n"
2724               + "      {\n"
2725               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2726               + "        \"pdb_id\":\"1rwe\",\n"
2727               + "        \"resolution\":1.8,\n"
2728               + "        \"title\":\"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues\"},\n"
2729               + "      {\n"
2730               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2731               + "        \"pdb_id\":\"1rwe\",\n"
2732               + "        \"resolution\":1.8,\n"
2733               + "        \"title\":\"Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8 analogues\"},\n"
2734               + "      {\n"
2735               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2736               + "        \"pdb_id\":\"1evr\",\n"
2737               + "        \"resolution\":1.9,\n"
2738               + "        \"title\":\"The structure of the resorcinol/insulin R6 hexamer\"},\n"
2739               + "      {\n"
2740               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2741               + "        \"pdb_id\":\"1g7b\",\n"
2742               + "        \"resolution\":1.3,\n"
2743               + "        \"title\":\"1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K\"},\n"
2744               + "      {\n"
2745               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2746               + "        \"pdb_id\":\"1g7b\",\n"
2747               + "        \"resolution\":1.3,\n"
2748               + "        \"title\":\"1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K\"},\n"
2749               + "      {\n"
2750               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2751               + "        \"pdb_id\":\"1ben\",\n"
2752               + "        \"resolution\":1.4,\n"
2753               + "        \"title\":\"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE\"},\n"
2754               + "      {\n"
2755               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2756               + "        \"pdb_id\":\"1lph\",\n"
2757               + "        \"resolution\":2.3,\n"
2758               + "        \"title\":\"LYS(B28)PRO(B29)-HUMAN INSULIN\"},\n"
2759               + "      {\n"
2760               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2761               + "        \"pdb_id\":\"1lph\",\n"
2762               + "        \"resolution\":2.3,\n"
2763               + "        \"title\":\"LYS(B28)PRO(B29)-HUMAN INSULIN\"},\n"
2764               + "      {\n"
2765               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2766               + "        \"pdb_id\":\"2om1\",\n"
2767               + "        \"resolution\":1.97,\n"
2768               + "        \"title\":\"Structure of human insulin in presence of thiocyanate at pH 6.5\"},\n"
2769               + "      {\n"
2770               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2771               + "        \"pdb_id\":\"2om0\",\n"
2772               + "        \"resolution\":2.05,\n"
2773               + "        \"title\":\"Structure of human insulin in presence of urea at pH 6.5\"},\n"
2774               + "      {\n"
2775               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2776               + "        \"pdb_id\":\"2om0\",\n"
2777               + "        \"resolution\":2.05,\n"
2778               + "        \"title\":\"Structure of human insulin in presence of urea at pH 6.5\"},\n"
2779               + "      {\n"
2780               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2781               + "        \"pdb_id\":\"1g7a\",\n"
2782               + "        \"resolution\":1.2,\n"
2783               + "        \"title\":\"1.2 A structure of T3R3 human insulin at 100 K\"},\n"
2784               + "      {\n"
2785               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2786               + "        \"pdb_id\":\"1g7a\",\n"
2787               + "        \"resolution\":1.2,\n"
2788               + "        \"title\":\"1.2 A structure of T3R3 human insulin at 100 K\"},\n"
2789               + "      {\n"
2790               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2791               + "        \"pdb_id\":\"6ck2\",\n"
2792               + "        \"resolution\":2.25,\n"
2793               + "        \"title\":\"Insulin analog containing a YB26W mutation\"},\n"
2794               + "      {\n"
2795               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2796               + "        \"pdb_id\":\"5udp\",\n"
2797               + "        \"resolution\":1.348,\n"
2798               + "        \"title\":\"High resolution x-ray crystal structure of synthetic insulin lispro\"},\n"
2799               + "      {\n"
2800               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2801               + "        \"pdb_id\":\"5udp\",\n"
2802               + "        \"resolution\":1.348,\n"
2803               + "        \"title\":\"High resolution x-ray crystal structure of synthetic insulin lispro\"},\n"
2804               + "      {\n"
2805               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2806               + "        \"pdb_id\":\"5mt3\",\n"
2807               + "        \"resolution\":2.02,\n"
2808               + "        \"title\":\"Human insulin in complex with serotonin and arginine\"},\n"
2809               + "      {\n"
2810               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2811               + "        \"pdb_id\":\"6nwv\",\n"
2812               + "        \"resolution\":1.601,\n"
2813               + "        \"title\":\"Insulin Lispro Analog\"},\n"
2814               + "      {\n"
2815               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2816               + "        \"pdb_id\":\"6gnq\",\n"
2817               + "        \"resolution\":2.2,\n"
2818               + "        \"title\":\"Monoclinic crystalline form of human insulin, complexed with meta-cresol\"},\n"
2819               + "      {\n"
2820               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2821               + "        \"pdb_id\":\"5hrq\",\n"
2822               + "        \"resolution\":1.28,\n"
2823               + "        \"title\":\"Insulin with proline analog HzP at position B28 in the R6 state\"},\n"
2824               + "      {\n"
2825               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2826               + "        \"pdb_id\":\"5hpr\",\n"
2827               + "        \"resolution\":1.33,\n"
2828               + "        \"title\":\"Insulin with proline analog HyP at position B28 in the T2 state\"},\n"
2829               + "      {\n"
2830               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2831               + "        \"pdb_id\":\"5hpr\",\n"
2832               + "        \"resolution\":1.33,\n"
2833               + "        \"title\":\"Insulin with proline analog HyP at position B28 in the T2 state\"},\n"
2834               + "      {\n"
2835               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2836               + "        \"pdb_id\":\"5ems\",\n"
2837               + "        \"resolution\":2.3,\n"
2838               + "        \"title\":\"Crystal Structure of an iodinated insulin analog\"},\n"
2839               + "      {\n"
2840               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2841               + "        \"pdb_id\":\"4ajx\",\n"
2842               + "        \"resolution\":1.2,\n"
2843               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
2844               + "      {\n"
2845               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2846               + "        \"pdb_id\":\"4ajx\",\n"
2847               + "        \"resolution\":1.2,\n"
2848               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
2849               + "      {\n"
2850               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2851               + "        \"pdb_id\":\"3v1g\",\n"
2852               + "        \"resolution\":2.2,\n"
2853               + "        \"title\":\"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health\"},\n"
2854               + "      {\n"
2855               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2856               + "        \"pdb_id\":\"3v1g\",\n"
2857               + "        \"resolution\":2.2,\n"
2858               + "        \"title\":\"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health\"},\n"
2859               + "      {\n"
2860               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2861               + "        \"pdb_id\":\"3zqr\",\n"
2862               + "        \"resolution\":1.9,\n"
2863               + "        \"title\":\"NMePheB25 insulin analogue crystal structure\"},\n"
2864               + "      {\n"
2865               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2866               + "        \"pdb_id\":\"3zqr\",\n"
2867               + "        \"resolution\":1.9,\n"
2868               + "        \"title\":\"NMePheB25 insulin analogue crystal structure\"},\n"
2869               + "      {\n"
2870               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2871               + "        \"pdb_id\":\"4ajz\",\n"
2872               + "        \"resolution\":1.8,\n"
2873               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
2874               + "      {\n"
2875               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2876               + "        \"pdb_id\":\"3v19\",\n"
2877               + "        \"resolution\":2.0,\n"
2878               + "        \"title\":\"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health\"},\n"
2879               + "      {\n"
2880               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2881               + "        \"pdb_id\":\"3v19\",\n"
2882               + "        \"resolution\":2.0,\n"
2883               + "        \"title\":\"Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of protein engineering to global health\"},\n"
2884               + "      {\n"
2885               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2886               + "        \"pdb_id\":\"3zs2\",\n"
2887               + "        \"resolution\":1.97,\n"
2888               + "        \"title\":\"TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure\"},\n"
2889               + "      {\n"
2890               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2891               + "        \"pdb_id\":\"3zs2\",\n"
2892               + "        \"resolution\":1.97,\n"
2893               + "        \"title\":\"TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure\"},\n"
2894               + "      {\n"
2895               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2896               + "        \"pdb_id\":\"5mt9\",\n"
2897               + "        \"resolution\":1.88,\n"
2898               + "        \"title\":\"Human insulin in complex with serotonin and arginine\"},\n"
2899               + "      {\n"
2900               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2901               + "        \"pdb_id\":\"5uru\",\n"
2902               + "        \"resolution\":2.41,\n"
2903               + "        \"title\":\"Insulin with proline analog DhP at position B28 in the R6 state\"},\n"
2904               + "      {\n"
2905               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2906               + "        \"pdb_id\":\"5uu3\",\n"
2907               + "        \"resolution\":2.25,\n"
2908               + "        \"title\":\"Insulin with proline analog DfP at position B28 in the R6 state\"},\n"
2909               + "      {\n"
2910               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2911               + "        \"pdb_id\":\"3kq6\",\n"
2912               + "        \"resolution\":1.9,\n"
2913               + "        \"title\":\"Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural principles of a novel long-acting insulin analog\"},\n"
2914               + "      {\n"
2915               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2916               + "        \"pdb_id\":\"3kq6\",\n"
2917               + "        \"resolution\":1.9,\n"
2918               + "        \"title\":\"Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural principles of a novel long-acting insulin analog\"},\n"
2919               + "      {\n"
2920               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2921               + "        \"pdb_id\":\"4akj\",\n"
2922               + "        \"resolution\":2.01,\n"
2923               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
2924               + "      {\n"
2925               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2926               + "        \"pdb_id\":\"5uss\",\n"
2927               + "        \"resolution\":2.061,\n"
2928               + "        \"title\":\"Insulin with proline analog PiP at position B28 in the R6 state\"},\n"
2929               + "      {\n"
2930               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2931               + "        \"pdb_id\":\"5uss\",\n"
2932               + "        \"resolution\":2.061,\n"
2933               + "        \"title\":\"Insulin with proline analog PiP at position B28 in the R6 state\"},\n"
2934               + "      {\n"
2935               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
2936               + "        \"pdb_id\":\"6hn5\",\n"
2937               + "        \"resolution\":3.2,\n"
2938               + "        \"title\":\"Leucine-zippered human insulin receptor ectodomain with single bound insulin - \\\"upper\\\" membrane-distal part\"},\n"
2939               + "      {\n"
2940               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2941               + "        \"pdb_id\":\"2wc0\",\n"
2942               + "        \"resolution\":2.8,\n"
2943               + "        \"title\":\"crystal structure of human insulin degrading enzyme in complex with iodinated insulin\"},\n"
2944               + "      {\n"
2945               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2946               + "        \"pdb_id\":\"2wc0\",\n"
2947               + "        \"resolution\":2.8,\n"
2948               + "        \"title\":\"crystal structure of human insulin degrading enzyme in complex with iodinated insulin\"},\n"
2949               + "      {\n"
2950               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
2951               + "        \"pdb_id\":\"6sof\",\n"
2952               + "        \"resolution\":4.3,\n"
2953               + "        \"title\":\"human insulin receptor ectodomain bound by 4 insulin\"},\n"
2954               + "      {\n"
2955               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2956               + "        \"pdb_id\":\"6z7y\",\n"
2957               + "        \"resolution\":2.2,\n"
2958               + "        \"title\":\"Human insulin in complex with the analytical antibody OXI-005 Fab\"},\n"
2959               + "      {\n"
2960               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2961               + "        \"pdb_id\":\"6z7y\",\n"
2962               + "        \"resolution\":2.2,\n"
2963               + "        \"title\":\"Human insulin in complex with the analytical antibody OXI-005 Fab\"},\n"
2964               + "      {\n"
2965               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2966               + "        \"pdb_id\":\"2omh\",\n"
2967               + "        \"resolution\":1.36,\n"
2968               + "        \"title\":\"Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea\"},\n"
2969               + "      {\n"
2970               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2971               + "        \"pdb_id\":\"2omh\",\n"
2972               + "        \"resolution\":1.36,\n"
2973               + "        \"title\":\"Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea\"},\n"
2974               + "      {\n"
2975               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2976               + "        \"pdb_id\":\"2omg\",\n"
2977               + "        \"resolution\":1.52,\n"
2978               + "        \"title\":\"Structure of human insulin cocrystallized with protamine and urea\"},\n"
2979               + "      {\n"
2980               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2981               + "        \"pdb_id\":\"3fq9\",\n"
2982               + "        \"resolution\":1.35,\n"
2983               + "        \"title\":\"Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications\"},\n"
2984               + "      {\n"
2985               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2986               + "        \"pdb_id\":\"3fq9\",\n"
2987               + "        \"resolution\":1.35,\n"
2988               + "        \"title\":\"Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications\"},\n"
2989               + "      {\n"
2990               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2991               + "        \"pdb_id\":\"3jsd\",\n"
2992               + "        \"resolution\":2.5,\n"
2993               + "        \"title\":\"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus\"},\n"
2994               + "      {\n"
2995               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
2996               + "        \"pdb_id\":\"3jsd\",\n"
2997               + "        \"resolution\":2.5,\n"
2998               + "        \"title\":\"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus\"},\n"
2999               + "      {\n"
3000               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3001               + "        \"pdb_id\":\"4p65\",\n"
3002               + "        \"resolution\":1.5,\n"
3003               + "        \"title\":\"Crystal structure of an cyclohexylalanine substituted insulin analog.\"},\n"
3004               + "      {\n"
3005               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3006               + "        \"pdb_id\":\"4p65\",\n"
3007               + "        \"resolution\":1.5,\n"
3008               + "        \"title\":\"Crystal structure of an cyclohexylalanine substituted insulin analog.\"},\n"
3009               + "      {\n"
3010               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3011               + "        \"pdb_id\":\"3p33\",\n"
3012               + "        \"resolution\":2.3,\n"
3013               + "        \"title\":\"Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state at the expense of activity\"},\n"
3014               + "      {\n"
3015               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3016               + "        \"pdb_id\":\"3p2x\",\n"
3017               + "        \"resolution\":2.0,\n"
3018               + "        \"title\":\"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity\"},\n"
3019               + "      {\n"
3020               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3021               + "        \"pdb_id\":\"3p2x\",\n"
3022               + "        \"resolution\":2.0,\n"
3023               + "        \"title\":\"Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state at the expense of activity\"},\n"
3024               + "      {\n"
3025               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3026               + "        \"pdb_id\":\"1qiz\",\n"
3027               + "        \"resolution\":2.0,\n"
3028               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL\"},\n"
3029               + "      {\n"
3030               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3031               + "        \"pdb_id\":\"1qiz\",\n"
3032               + "        \"resolution\":2.0,\n"
3033               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL\"},\n"
3034               + "      {\n"
3035               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3036               + "        \"pdb_id\":\"1ben\",\n"
3037               + "        \"resolution\":1.4,\n"
3038               + "        \"title\":\"INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE\"},\n"
3039               + "      {\n"
3040               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3041               + "        \"pdb_id\":\"2oly\",\n"
3042               + "        \"resolution\":1.7,\n"
3043               + "        \"title\":\"Structure of human insulin in presence of urea at pH 7.0\"},\n"
3044               + "      {\n"
3045               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3046               + "        \"pdb_id\":\"2om1\",\n"
3047               + "        \"resolution\":1.97,\n"
3048               + "        \"title\":\"Structure of human insulin in presence of thiocyanate at pH 6.5\"},\n"
3049               + "      {\n"
3050               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3051               + "        \"pdb_id\":\"6ck2\",\n"
3052               + "        \"resolution\":2.25,\n"
3053               + "        \"title\":\"Insulin analog containing a YB26W mutation\"},\n"
3054               + "      {\n"
3055               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3056               + "        \"pdb_id\":\"6tyh\",\n"
3057               + "        \"resolution\":1.600019,\n"
3058               + "        \"title\":\"Four-Disulfide Insulin Analog A22/B22\"},\n"
3059               + "      {\n"
3060               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3061               + "        \"pdb_id\":\"6tyh\",\n"
3062               + "        \"resolution\":1.600019,\n"
3063               + "        \"title\":\"Four-Disulfide Insulin Analog A22/B22\"},\n"
3064               + "      {\n"
3065               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3066               + "        \"pdb_id\":\"5mt3\",\n"
3067               + "        \"resolution\":2.02,\n"
3068               + "        \"title\":\"Human insulin in complex with serotonin and arginine\"},\n"
3069               + "      {\n"
3070               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3071               + "        \"pdb_id\":\"6nwv\",\n"
3072               + "        \"resolution\":1.601,\n"
3073               + "        \"title\":\"Insulin Lispro Analog\"},\n"
3074               + "      {\n"
3075               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3076               + "        \"pdb_id\":\"5hpu\",\n"
3077               + "        \"resolution\":2.2,\n"
3078               + "        \"title\":\"Insulin with proline analog HyP at position B28 in the R6 state\"},\n"
3079               + "      {\n"
3080               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3081               + "        \"pdb_id\":\"5hpu\",\n"
3082               + "        \"resolution\":2.2,\n"
3083               + "        \"title\":\"Insulin with proline analog HyP at position B28 in the R6 state\"},\n"
3084               + "      {\n"
3085               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3086               + "        \"pdb_id\":\"5hrq\",\n"
3087               + "        \"resolution\":1.28,\n"
3088               + "        \"title\":\"Insulin with proline analog HzP at position B28 in the R6 state\"},\n"
3089               + "      {\n"
3090               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3091               + "        \"pdb_id\":\"4ajz\",\n"
3092               + "        \"resolution\":1.8,\n"
3093               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
3094               + "      {\n"
3095               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3096               + "        \"pdb_id\":\"5mt9\",\n"
3097               + "        \"resolution\":1.88,\n"
3098               + "        \"title\":\"Human insulin in complex with serotonin and arginine\"},\n"
3099               + "      {\n"
3100               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3101               + "        \"pdb_id\":\"5uru\",\n"
3102               + "        \"resolution\":2.41,\n"
3103               + "        \"title\":\"Insulin with proline analog DhP at position B28 in the R6 state\"},\n"
3104               + "      {\n"
3105               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3106               + "        \"pdb_id\":\"5uu3\",\n"
3107               + "        \"resolution\":2.25,\n"
3108               + "        \"title\":\"Insulin with proline analog DfP at position B28 in the R6 state\"},\n"
3109               + "      {\n"
3110               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3111               + "        \"pdb_id\":\"5uu4\",\n"
3112               + "        \"resolution\":1.973,\n"
3113               + "        \"title\":\"Insulin with proline analog ThioP at position B28 in the R6 state\"},\n"
3114               + "      {\n"
3115               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3116               + "        \"pdb_id\":\"5uu4\",\n"
3117               + "        \"resolution\":1.973,\n"
3118               + "        \"title\":\"Insulin with proline analog ThioP at position B28 in the R6 state\"},\n"
3119               + "      {\n"
3120               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3121               + "        \"pdb_id\":\"5bqq\",\n"
3122               + "        \"resolution\":1.54,\n"
3123               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B27 and B30\"},\n"
3124               + "      {\n"
3125               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3126               + "        \"pdb_id\":\"5mam\",\n"
3127               + "        \"resolution\":2.2,\n"
3128               + "        \"title\":\"Human insulin in complex with serotonin\"},\n"
3129               + "      {\n"
3130               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3131               + "        \"pdb_id\":\"5mam\",\n"
3132               + "        \"resolution\":2.2,\n"
3133               + "        \"title\":\"Human insulin in complex with serotonin\"},\n"
3134               + "      {\n"
3135               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3136               + "        \"pdb_id\":\"4akj\",\n"
3137               + "        \"resolution\":2.01,\n"
3138               + "        \"title\":\"Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engineered acylated insulin\"},\n"
3139               + "      {\n"
3140               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3141               + "        \"pdb_id\":\"1q4v\",\n"
3142               + "        \"resolution\":2.0,\n"
3143               + "        \"title\":\"CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR\"},\n"
3144               + "      {\n"
3145               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3146               + "        \"pdb_id\":\"4xc4\",\n"
3147               + "        \"resolution\":1.499,\n"
3148               + "        \"title\":\"Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide\"},\n"
3149               + "      {\n"
3150               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3151               + "        \"pdb_id\":\"4xc4\",\n"
3152               + "        \"resolution\":1.499,\n"
3153               + "        \"title\":\"Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide\"},\n"
3154               + "      {\n"
3155               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
3156               + "        \"pdb_id\":\"6sof\",\n"
3157               + "        \"resolution\":4.3,\n"
3158               + "        \"title\":\"human insulin receptor ectodomain bound by 4 insulin\"},\n"
3159               + "      {\n"
3160               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
3161               + "        \"pdb_id\":\"6sof\",\n"
3162               + "        \"resolution\":4.3,\n"
3163               + "        \"title\":\"human insulin receptor ectodomain bound by 4 insulin\"},\n"
3164               + "      {\n"
3165               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3166               + "        \"pdb_id\":\"6z7y\",\n"
3167               + "        \"resolution\":2.2,\n"
3168               + "        \"title\":\"Human insulin in complex with the analytical antibody OXI-005 Fab\"},\n"
3169               + "      {\n"
3170               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3171               + "        \"pdb_id\":\"6z7y\",\n"
3172               + "        \"resolution\":2.2,\n"
3173               + "        \"title\":\"Human insulin in complex with the analytical antibody OXI-005 Fab\"},\n"
3174               + "      {\n"
3175               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3176               + "        \"pdb_id\":\"1zeh\",\n"
3177               + "        \"resolution\":1.5,\n"
3178               + "        \"title\":\"STRUCTURE OF INSULIN\"},\n"
3179               + "      {\n"
3180               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3181               + "        \"pdb_id\":\"1zeh\",\n"
3182               + "        \"resolution\":1.5,\n"
3183               + "        \"title\":\"STRUCTURE OF INSULIN\"},\n"
3184               + "      {\n"
3185               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3186               + "        \"pdb_id\":\"1qiy\",\n"
3187               + "        \"resolution\":2.3,\n"
3188               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL\"},\n"
3189               + "      {\n"
3190               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3191               + "        \"pdb_id\":\"1qiy\",\n"
3192               + "        \"resolution\":2.3,\n"
3193               + "        \"title\":\"HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL\"},\n"
3194               + "      {\n"
3195               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3196               + "        \"pdb_id\":\"2oly\",\n"
3197               + "        \"resolution\":1.7,\n"
3198               + "        \"title\":\"Structure of human insulin in presence of urea at pH 7.0\"},\n"
3199               + "      {\n"
3200               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3201               + "        \"pdb_id\":\"3rov\",\n"
3202               + "        \"resolution\":2.3,\n"
3203               + "        \"title\":\"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus\"},\n"
3204               + "      {\n"
3205               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3206               + "        \"pdb_id\":\"3rov\",\n"
3207               + "        \"resolution\":2.3,\n"
3208               + "        \"title\":\"Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal diabetes mellitus\"},\n"
3209               + "      {\n"
3210               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3211               + "        \"pdb_id\":\"5bqq\",\n"
3212               + "        \"resolution\":1.54,\n"
3213               + "        \"title\":\"Human insulin with intra-chain chemical crosslink between modified B27 and B30\"},\n"
3214               + "      {\n"
3215               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3216               + "        \"pdb_id\":\"1q4v\",\n"
3217               + "        \"resolution\":2.0,\n"
3218               + "        \"title\":\"CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANISM OF RECEPTOR\"},\n"
3219               + "      {\n"
3220               + "        \"experimental_method\":[\"Electron Microscopy\"],\n"
3221               + "        \"pdb_id\":\"6sof\",\n"
3222               + "        \"resolution\":4.3,\n"
3223               + "        \"title\":\"human insulin receptor ectodomain bound by 4 insulin\"},\n"
3224               + "      {\n"
3225               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3226               + "        \"pdb_id\":\"6z7w\",\n"
3227               + "        \"resolution\":2.42,\n"
3228               + "        \"title\":\"Human insulin in complex with the analytical antibody HUI-018 Fab\"},\n"
3229               + "      {\n"
3230               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3231               + "        \"pdb_id\":\"6z7w\",\n"
3232               + "        \"resolution\":2.42,\n"
3233               + "        \"title\":\"Human insulin in complex with the analytical antibody HUI-018 Fab\"},\n"
3234               + "      {\n"
3235               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3236               + "        \"pdb_id\":\"1zeg\",\n"
3237               + "        \"resolution\":1.6,\n"
3238               + "        \"title\":\"STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL\"},\n"
3239               + "      {\n"
3240               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3241               + "        \"pdb_id\":\"5uqa\",\n"
3242               + "        \"resolution\":1.3100024,\n"
3243               + "        \"title\":\"Insulin with proline analog FzP at position B28 in the R6 state\"},\n"
3244               + "      {\n"
3245               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3246               + "        \"pdb_id\":\"6z7w\",\n"
3247               + "        \"resolution\":2.42,\n"
3248               + "        \"title\":\"Human insulin in complex with the analytical antibody HUI-018 Fab\"},\n"
3249               + "      {\n"
3250               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3251               + "        \"pdb_id\":\"6z7w\",\n"
3252               + "        \"resolution\":2.42,\n"
3253               + "        \"title\":\"Human insulin in complex with the analytical antibody HUI-018 Fab\"},\n"
3254               + "      {\n"
3255               + "        \"experimental_method\":[\"X-ray diffraction\"],\n"
3256               + "        \"pdb_id\":\"1xda\",\n"
3257               + "        \"resolution\":1.8,\n"
3258               + "        \"title\":\"STRUCTURE OF INSULIN\"}]\n"
3259               + "  }}"
3260
3261     }};
3262     createMockFTSRestClient((FTSRestClient)getInstance(), mocks);
3263   }
3264 }